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Abstract 
Pleurotus tuber-regium (Ptr) is a tropical sclerotial mushroom which has been 
gaining an emerging interest in terms of its nutritional, medicinal and economic 
values. Bioactive components, especially polysaccharides isolated from the Ptr 
sclerotium have indicated that it can be used as functional food products, in 
particular for their antitumor and antiviral effects. In order to develop Ptr sclerotium 
as functional food products, the safety of its consumption was determined by toxicity 
tests in here. In addition, a number of mushrooms have been shown to have 
protective effect in rats against liver injury induced by chemicals. Hence, the liver 
protection potential of Ptr sclerotium was investigated as well. 
Acute toxicity of Ptr sclerotium was evaluated by single dose feeding of male 
S.D. rats (4 week-old) with two sclerotium-based diets containing 66.67% and 75% 
Ptr sclerotium (equivalent to 56.1 and 72.8 g/kg body wt., respectively). There were 
no significant differences in the serum levels of glutamate pyruvate transaminase 
(SGPT) and glutamate oxaloacetate transaminase (SGOT) between the two 
sclerotium-based diet groups and normal rodent diet group. No abnormal change was 
observed under light microscope in the liver section of rats fed with the two Ptr 
sclerotium-based diets. The No-Observable-Adversed-Effect-Level (NOAEL) found 
in the acute toxicity test of Ptr sclerotium was 80.26 g/kg body wt.. 
Growing S.D. rats (4 week-old) were fed with three diets containing 0%, 5% 
and 20% of Ptr sclerotium during a 30-day sub-acute and 90-day sub-chronic toxicity 
tests. In the sub-acute toxicity test, there were no adverse changes detected in the 
II 
animals of the treatment groups in terms of body weight gain, organ-per-body weight 
ratio, and histopathological study in liver. Only the levels of blood urea nitrogen 
(BUN) of the 5% sclerotium-based diet and serum alkaline phosphatase (AP) of the ‘ 
20% sclerotium-based diet were significantly (p < 0.05) lower than those of the 
control. 
In the 90-day sub-chronic toxicity test, the body weight gain in male rats (4 
week-old) was significantly (p < 0.05) higher than that of the female (4 week-old). 
Liver-per-body weight of the female and male rats fed with 20%, and male rats fed 
with 5% Ptr sclerotium-based diet were significantly (p < 0.05) lower than that of the 
control. No significant changes in the biochemical assays and microscopic 
histopathological studies were observed in all the rats except the male rats fed with 
20% Ptr sclerotium-based diet, which had slight but significant (p < 0.05) elevation 
of SGPT activity. Male rats seemed to be more susceptible to the changes induced by 
the feeding of Ptr sclerotium-based diets. The NOAEL of Ptr sclerotium in the 
90-day sub-chronic experiment was found to be 6.44 g/kg body wt./day. 
Ptr sclerotium showed preventive hepatoprotection against carbon tetrachloride 
in male S.D. rats fed with 30% sclerotium-based diet for 7 days before the 
intraperitoneal administration of CCI4 at 0.7ml/kg body wt.. Significantly (p < 0.05) 
lower SGOT was found in the 30% sclerotium-based diet group as compared to the 
control. When a dose of 1.5 ml/kg CCI4 were administered to the male rats before the 
feeding of 30% Ptr sclerotium-based diet, liver-per-body weight of the animals was 
significantly (p < 0.05) lower than that of the CCI4 control. This suggested that Ptr 
sclerotium-based diet is able to reduce hepatic injury as well as increase the rate of 
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hepatic recovery after the intoxication of CCI4. 
Seven-day pre-feeding of 30% Ptr sclerolium-based diet had significantly 
reduced hepatotoxic and genotoxic effects produced by i.p. administration of 0.7 
mg/kg aflatoxin Bi (AFBi) in male S.D. rats. Animals in the Ptr sclerotium-based 
diet group had significant (p < 0.05) reduction in the AFBi-induced SGPT and SGOT 
levels by 64.0% and 54.6%, respectively. Liver-per-body weight of the 30% Ptr 
sclerotium-based diet group was significantly (p < 0.05) higher than that of the AFBi 
control group. Feeding of Ptr sclerotium-based diet had also reduced the DNA 
damage induced by AFBi as measured by the comet assay. Tail DNA and olive tail 
moment of the 30% Ptr sclerotium-based diet group were significantly lower (p < 
0.05) than that of the AFBi control group by 37.4% and 43.2%, respectively. These 
indicated that Ptr sclerotium has hepato- and geno-protection against AFBi 





































彗星分析法（comet assay)顯示餓食虎奶薛菌核食糧亦降低了 AFBi所造成的 
DNA損害。虎奶链菌核食糧組的尾部DNA百份比（Tail DNA%)及Olive尾矩 
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Chapter 1 General Introduction 
1.1 Biology of Pleurotus tuber-regium (Ptr) 
1.1.1 Ptr grown in the wild 
Pleurotus tuber-regium (Ptr) is sclerotial mushroom which has been gaining an 
emerging interest over the world in terms of its nutritional, medicinal and economic 
values (Cheung and Lee, 2000; Huang et al., 1996; Huang and Hu, 2000; Ude et al., 
2001). Ptr is prevalent in Africa especially in Nigeria where it has been consumed by 
local people as food and medicine for many years. The geographic distribution of 
wild growing Ptr includes most of equatorial Africa, India, Sri Lanka, southeast Asia 
and northern Australia, as well as the southern Pacific (Pegler, 1983). Being a 
sclerotial mushroom, Ptr produces both sclerotia and fruiting bodies. Ptr can infect 
dry wood and produce sclerotium which grows under soil. Its sclerotium is large, 
sometimes up to 30cm or more in diameter and weighed over 5kg, spherical to ovoid 
shape, and subterranean. The sclerotium has dark brown skin and white compact 
mycelial tissue inside. Figure 1.1 shows the appearance of Ptr sclerotium. Under a 
warm and humid place, the sclerotium can continues to produce fruit bodies one after 
another over a period of time，with size depending on the size of the sclerotium (Oso, 
1977). In the field studies in Nigeria, Ptr was found commonly growing on D. oliveri, 
a medium-sized tree with bark usually peeled off the living trunk in flaky pieces. 
Mycelium is usually found growing on the fallen bark scattered around the living tree, 
but no living trees appear to be infected by this fungus. It has been deduced that Ptr 
is a saprophytic wood invader. Besides, mycelial strands, dried fruit bodies and 
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sclerotia have been found on and around dead standing trees and fallen logs 
(Okhuoya et al, 1990). 
1.1.2 Cultivation of Ptr 
In China, the cultivation methods of Ptr sclerotium (also known as tiger milk 
mushroom) have been established (Huang et al.’ 1996). The formulation of 
substratum, in percentage, was: cotton hulls 39%, sawdust 39%, wheat pollard 20%, 
calcium carbonate 1%, sugar 1% and water content kept at about 62% to 65% (to the 
dry materials). The substrates are sterilized in a bag and then inoculated with Ptr 
mycelia. The formation of sclerotium takes about 3 to 12 months. Under natural 
conditions in southern China (Fujian province), Ptr (tiger milk mushroom) can be 
cultivated 2 to 3 crops per year (Huang et al, 1996). 
P ‘ • JK'' A*, ： 
Fig. 1.1 The appearance of Ptr sclerotia 
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1.2 Functional food and pharmaceutical application of Ptr 
sclerotium 
1.2.1 Traditional food and medicinal uses of Ptr sclerotium 
Ptr is of significant economic value since both the fruit body and the sclerotium 
are edible. The sclerotium has also been used in Nigeria as a food additive for soup 
thickener and traditional medicine for the treatment of constipation, headache, 
stomach pain，high blood pressure, fever, boils and dental problems (Oso, 1977). The 
sclerotium is usually processed with other ingredients such as onion, pepper and 
palm oil by the native doctors to cure ailments. The preparation can be administered 
orally or applied as lotion to the patients (Oso, 1977). Ptr sclerotium has a high 
economic value because of its demand for use in many culinary dishes and medicinal 
preparations in Nigeria and across West Africa (Isikhuemhen et al. 2000; Oso 1977). 
In the preparation of the popular melon (egusi) soup in Nigeria and neighbouring 
countries, it serves as a substitute f o r � e g u s i seeds' {Citrulus vulgaris) (Nwokolo, 
1987). In Ghana, the sclerotium is used mainly for medicinal purposes and for 
treating malnourished babies. The need for commercial cultivation of this mushroom 
has become very important because of its numerous applications and uses in the 
West African sub-region. Generally, it is the sclerotium of this fungus that is of 
interest because they can be stored for a long time without loss of viability and can 
later be used as food or medicinal preparations when subjected to sporophore 
induction, to produce the fruit body. 
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1.2.2 Nutritional value and chemical composition 
There are wide ranges of nutritional values and chemical composition of Ptr 
sclerotium reported in the literature. It had been reported that the moisture content of 
air-dried Ptr sclerotium was 14.9% (Ude et al., 2001). The crude fiber content was 
found to be 13.1% (Ude et al, 2001) and 16.7% (Nwokolo, 1987). Both the 
sclerotium and fruit body of Ptr have a higher crude fiber than some cereals like 
maize and rice, and their protein content is higher than some fruits like banana and 
orange (Ude et al., 2001). The carbohydrates content was 57.8% (Ude et al., 2001) 
and the energy content reported was 3222 kcal/kg (Nwokolo, 1987). The protein 
content of Ptr sclerotium was reported as 9.2% (Ude et al., 2001), and 13.0% (dry 
mass basis) which was found to be lower than that in its pileus (14.6-36.4% dry mass 
basis) (Ogundana and Fagade, 1982; Nwokolo，1986). The mineral content of Ptr 
sclerotium in terms of potassium was reported as 0.5% (Ude et al., 2001) and 0.35% 
(Nwokolo, 1987); while the sodium content was 0.6% (Ude et al., 2001). The amino 
acid and the mineral content of Ptr sclerotium are shown in table 1.1 and 1.2, 
respectively (Nwokolo, 1987). Ptr sclerotium has a low lipid content, reporting as 
1.0% (Nwokolo, 1987) and 3.0% (Ude et al., 2001). 
However it should be noted that Ptr sclerotium consists mainly of nonnutritive 
dietary fiber (Cheung and Lee, 1998), the amount of digestible energy (DE) is 
actually low. Over the past decade, many foods have been investigated on their 
potential in providing specific physiologic, health-promoting and disease-preventing 
benefits, associated with the concepts of “designer foods,” "functional foods," and 
“nutraceuticals”. Nutraceuticals and functional foods are foods that provide 
demonstrated physiological benefits or reduce the risk of chronic disease, above and 
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beyond their basic nutritional functions (Sadler and Saltmarsh, 1998). A functional 
food is similar to a conventional food, while a nutraceutical is isolated from a food 
and sold in dosage form, in both cases the active components occur naturally in the 
food (Sadler and Saltmarsh, 1998). Unmodified whole foods represent the simplest 
form of a functional food, for example, broccoli, carrots, or tomatoes are considered 
as functional foods because they are rich in such physiologically active components 
as sulforaphane, beta carotene, and lycopene, respectively. Modified foods, including 
those that have been fortified with nutrients or enhanced with phytochemicals or 
botanicals, also fall within the realm of functional foods (ADA, 2004). The 
evaluation of food is not only in terms of macronulrient and micronutrient content 
alone, but also the analyses of the content of other physiologically active components 
and their role in health promotion. The following paragraphs introduce the findings 
of Ptr as a functional food, including the nutritional value, anti-tumor and anti-viral 
activities in the components of Ptr scleroita. 
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Table 1.1. The amino acid content of Ptr sclerotium. 
Amino acids (mg/g) P. tuber regium 
Aspartic acid 11.3 土 0.4* 
Threonine 4.5 ±0.1 
Serine 3.8 士 0.1 
Glutamic acid 9.2 士 0.4 
Proline 6.1 土 0.2 
Glycine 4.5 ±0.1 
Alanine 3.9 士 0.1 
Cystine 0.3 士 0.0 
Valine 5.1 士 0.1 
Methionine 0.7 ± 0.0 
Isoleucine 4.2 士 0.1 
Leucine 6.6 ± 0.2 
Tyrosine 3.1 士 0.1 
Phenylalanine 4.3 士 0.1 
Histidine 4.2 士 0.1 
Lysine 0.7 土 0.0 
Arginine 4.6 ±0.1 
Total Amino Acids 77.1 ± 1.3 
*Values are means 士 S.E.M. (Nwokolo, 1987) 
Table 1.2. The mineral content of Ptr sclerotium. 
Minerals P. tuber regium 
Phosphorus (ppm) 2140 ± 88* 
Calcium (ppm) 320 土 10 
Magnesium (ppm) 1120 ± 45 
Potassium (ppm) 3520 士 105 
Copper (ppm) 11 士 0.0 
Manganese (ppm) 19 ± 0.3 
Zinc (ppm) 24 士 0.4 
Iron (ppm) 22 士 0.5 
Values are means 士 S.E.M. (Nwokolo, 1987) 
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1.2.3 Anti-tumor activity 
Some studies on the isolation of bioactive components, especially 
polysaccharides from the Ptr sclerotia have indicated that they can be used as 
functional food products. Ptr sclerotia are extremely rich in dietary fiber or nonstarch 
polysaccharides (NSPs) that are mainly composed of /?-glucans (Cheung and Lee, 
2000). p-D-glucans have been reported to have antitumoral effects and 
immunological activity (Muller et al” 1996; Kulicke et al., 1997; Zaidman et al., 
2005). An alkali-soluble polysaccharide (Hunai polysaccharide) from Ptr sclerotium 
has a p-(l->3)-linked D-glucopyranosyl backbone with a single P-D-glucopyranosyl 
group at 0 - 6 of every third glucose residue (Deng et al” 2000). Many NSPs isolated 
from mushroom such as grifolan from Grifola frondosa, lentinan from Lentinus 
edodes, and schizophyllan from Schizophyllum commune have been reported to have 
antitumor activity (Chihara et al., 1969; Mizuno, 1999). It has been revealed that the 
alkali soluble y^-glucan isolated from Ptr sclerotia possess a potential antitumor effect 
(Zhang et al., 2001). The in vitro test on the human tumor cell line, human acute 
promyelocytic leukemia (HL-60) and human hepatocellular carcinoma (HepG2) 
showed that hot alkali extract polysaccharide with weight-average molecular weight 
in the range of (5.8 - 42.2) x lO* had antiproliferative activity (Zhang et al., 2001). 
While the in vivo test using BALB/c mice implanted with solid tumor Sarcoma 180, 
the HAEs with weight-average molecular weights of (5.8 - 17.1) x lO^ showed 
effective inhibition of tumor proliferation with > 50% inhibition ratio (Zhang et al., 
2001). 
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1.2.4 Anti-viral activity 
Apart from anti-tumor activity, the hot alkali y^glucan extracts from Ptr 
sclerotia, when sulfated, showed anti-viral activity (Zhang et al., 2004). The 
experiments included the in vitro cytopathic effect assay (CPE) and plaque reduction 
assay (PRA) against herpes simplex viruses type 1 and 2 (HSV-1, -2), respiratory 
syncytial virus and influenza A virus. The sulfated y^glucans from Ptr sclerotium had 
potent anti-viral activity against HSV-2 (IC50 0.38 - 1.25 ^ig/mL) that was 
comparable to Acyclovir (an approved drug for the specific treatment of HSV 
infection in humans) (IC50 0.125 |ig/mL) as shown by the CPE assay. Results from 
PRA suggested that the sulfated y^-glucans seemed to prevent the virus particles from 
infecting the host cells by binding to them. It was speculated that the negative 
charged polymer chain of the sulfated /?-glucans interacted with the positively 
charged glycoproteins on the surface of HSV which minimized the interaction 
between the HSV and the negatively charged host cells. With no cytotoxicity to 
normal cells up to a concentration of 200^g/ml and having a strong inhibitory 
activity against HSV with an IC50 value comparable with known anti-HSV drugs, the 
authors suggested the sulfated /^glucans derived from Ptr sclerotia could be 
developed as an anti-HSV agent (Zhang et al, 2004). 
1.2.5 Immunologic function 
A study from China showed that polysaccharide in Ptr sclerotium has the 
functions of improving the immunity of the mouse, increasing the weight of animal's 
thymus and spleen, increasing the rate of carbon black clearing of mouse 
(phagocytosis activity)，and lengthening time of anaerobic resistance of mouse 
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(Huang and Hu, 2000). Sixty percent dry weight of Ptr sclerotium NSP was 
p-glucans (Cheung and Lee, 1998), which has been proven to enhance 
immunoreactivity, including activation of macrophages, cytotoxic T-cells and natural ‘ 
killer cells, that can up-regulate the immunological surveillance and the resistance of 
host against tumor cells (Kogan, 2000). The in vivo administration of 
(l-^3)-p-D-glucan to murine macrophages activated by lipopolysaccharide (LPS) 
induced the production of cytokines. These cytokines such as interleukin-1 and 
tumor necrosis factor alpha (TNF-a) could subsequently induce activation and 
differentiation of lymphocytes, and proliferation of granulocytes, enhancing 
cytotoxicity and in vivo immunomodulatory responses (Adachi et al., 1994; Chihara, 
1992). The hot alkaline extracts of (1~>3)-P-glucans from sclerotia of Ptr having 
different molecular weight (Mv) ranging from IxlO"^ to 42x1 O^  were 
carboxymethylated to derivatives (CMHAE) with Mv ranged from 2.08x1 O^  to 
53.2x1 o4, which resulted in enhanced water solubility and enhanced anti-tumor 
activity (Zhang et al., 2004). Carboxymethylation is a common chemical 
modification procedure for polysaccharides, which gives products in which the 
primary and/or secondary alcohol groups are etherified with carboxymethyl groups 
(DeNooy et al, 2000). The CMHAE fractions could increase TNF-a production in 
mice plasma stimulated by LPS (Zhang et al, 2004). 
1.2.6 Pharmaceutical application 
One of the most common dietary consumption of Ptr sclerotium in Nigeria is as 
a soup thickener，in which the sclerotium is cut and ground into powder and added to 
soup where it absorbs the water and swell. This arouses local scientists to investigate 
the possibility of this sclerotium in acting as a tablet disintegrant. In compressed 
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tablets, disintegrant facilitates the break up of the tablet in a liquid environment into 
fine particles before the dissolution of the active drug and its absorption from the 
gastro-intestinal tract. The study on physical characteristics of Ptr sclerotium has 
shown the cohesiveness of the powder, swelling capacity, water retention capacity, 
powder porosity, pH, and density (Iwuagwu et al., 2002). Results showed that Ptr 
sclerotium powder and maize starch BP, a commonly used tablet disintegrant, were 
pharmaceutically acceptable and similar. In some aspects, Ptr sclerotium powder is 
superior to maize starch BP as the disintegrant. Ptr sclerotium powder is neutral (pH 
=6.46) implying that when disperse in liquid medium, it will not produce an alkaline 
or acidic medium which causes product instability via effects on the gastro-intestinal 
tract absorption of the active drug. Moreover, the swelling capacity and water 
retention capacity of the Ptr sclerotium powder were more than two times of maize 
starch BP, respectively. In conclusion, Ptr sclerotium powder may therefore be used 
as an alternative disintegrant to maize starch BP (Iwuagwu et al., 2002). 
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Chapter 2 Toxicological evaluation on Ptr 
sclerotium 
2.1 Introduction 
2.1.1 Toxicological concern of Ptr sclerotium 
Despite the potential use of this mushroom sclerotium in food and other 
applications, its toxicological information is not known. In order to develop Ptr 
sclerotium as functional food products, the safety of its consumption should be 
determined. Over-consumption of many drugs may lead to adverse toxic effects. A 
toxicological screening study on Nigerian mushrooms, included Ptr fruit body has 
been previously reported (Fasidi and Kadiri, 1994). In this study, Ptr fruit body 
showed negative results in qualitative test of amatoxins and phallotoxins, which were 
known to have caused 90% of the reported deaths in 1924 to 1961 from poisoning by 
Amanita species (Buck, 1961). When rats were fed with aqueous extracts of Ptr fruit 
bodies for 10 days, there were no deaths or adverse clinical symptoms recorded and 
the biuret test for protein in their urine was also negative. This suggested that the 
fruit body of Ptr is safe for consumption (Fasidi and Kadiri, 1994). However, there is 
no detailed toxicological screening or study published for the Ptr sclerotium, though 
it is widely accepted as edible. Therefore, in this study, the first objective was to 
study the toxicology of Ptr sclerotium. Oral feeding of raw powdered sclerotium was 
mixed with other diet components and then used to feed the Sprague-Dawley rats. As 
Ptr sclerotium becomes popular and many studies have been conducted towards its 
potential for treatment and prevention of diseases or abnormalities, in which usually 
a relatively higher dose or continuous intake is preferred, study on its toxicological 
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effect on both animals and humans is of important value. 
2.1.2 Toxicological study 
Nutrients are necessary to sustain life and can be divided into macronutrients 
and micronutrient. Non-nutritive dietary constituents can be subdivided into 
compounds with adverse effect (toxicity) and beneficial effect. Food can be 
considered as a complex mixture of various compounds. Once ingested into the body, 
the food components are subjected to many changes. Figure 2.1 indicates the fate of 
a chemical inside human body. 
The definition of toxicological study varies from literatures to literatures. One 
of the concise definitions of toxicology is the study of the nature and mechanism of 
toxic effects of substances on living organisms and other biologic systems (Lu and 
Kacew，2002). Toxicity is rarely a single molecular event but is rather a cascade of 
events starting from exposure, proceeding through distribution and metabolism, and 
ending with interaction with cellular macromolecules (usually DNA or protein) and 
the expression of a toxic end point (Hodgson，2004). 
Like other chemicals, pesticides, drugs and food products which are to be 
released to the market, an evaluation of toxicology of Ptr sclerotium is necessary and 
was performed in this project. Due to the scope of time, acute (1 day), short-term (30 
days) and sub-chronic (90 days) tests were performed in preference to long-term 
chronic test. Most parts of this toxicological study were conducted according to the 
suggestions and requirements of the “Redbook 2000: Toxicological Principles for the 
Safety Assessment of Food Ingredients" (FDA, 2000) wherever it was applicable. It 
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is a guidance document that is intended to assist petitioners and notifiers in the 
development and submission of information used by the Food and Drug 
Administration in the safety assessment of food ingredients. “Redbook 2000” 
contains the information for the designing, conducting, and reporting the results of 
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Fig. 2.1 The sequence of events following the exposure of human to exogenous 
chemicals (Hodgson, 2004). 
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2.1.3 Biochemical methods for toxicological evaluation 
Biochemical assays involve the determination of the levels of various enzymes 
and other compounds in ones' body fluid. The specimens include the whole blood, 
plasma，serum, urine, etc.. These assays aid in diagnosis, treatment and prevention of 
disease. Originally released by cells, these enzymes or compounds in the particular fluid 
have their defined functions, otherwise, they are most likely to be released from cells as 
a result of ‘leakage，or cell death (Hodgson, 2004). In normal situation, these enzymes 
or compounds are released and removed in blood stream in an equilibrium way. The 
concentration of the certain analytes is governed by the rate of synthesis and release by 
cells, catabolism, excretion by kidney, and the hydration state of the animal (Hodgson, 
2004). The reasons for the loss of equilibrium may include the increase in cell 
membrane permeability, necrosis or severe damage to cell, the increase in rate of cell 
turnover, the intracellular induction by stimuli, and duct obstruction in which exocrine 
secretion re-entered into blood. The above mentioned situations are mostly the results of 
the responses or adverse effects produced by diseases or drugs. Since the intracellular 
concentrations of these analytes are much higher than that in the blood, a small degree 
of tissue damage may cause an increase in the concentration of the analytes (Lu and 
Kacew, 2002). This implies the requirement of high sensitivity in these biochemical 
assays. Since different type of cells will have its specific pattern of enzymes or 
concentrations of other compounds, the detection of certain kind of analytes reflects the 
location and provides clues for the diagnosis of disease. However, many important 
enzymes are widely distributed throughout the body with various concentrations, the 
localization of cellular damage and diagnostic specificity can be improved by (i) 
clinical history and examination to exclude non-pathological changes, (ii) measuring 
several enzymes, or (iii) isoenzyme study (Hoffmann, 1999). In recent years, the 
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enzymes and compounds used for the detection of injuries of target organs were well 
established and standardized by organizations such as WHO and USFDA (WHO, 1987; 
FDA, 2000). Serum enzymes level such as serum glutamate pyruvate transaminase 
(SGPT) and serum glutamate oxaloacetate transaminase (SGOT) are well adopted in 
recent toxicological studies and pharmacological studies of hepatoprotective effects 
of potential substances (Dwivedi, 1993; Gilani, 1995; Ooi, 1996; Huang, 2000; 
Wong，2000; Ulicna, 2003). In this research, a number of analytes were selected for 
the clinical assays on the toxicology of Ptr sclerotium. The selection of the analytes 
followed the preference stated in the FDA Redbook 2000. The summary of the 
analytes is tabulated in Table 2.2. 
2.1.3.1 Serum enzyme activities 
A. Serum glutamate pyruvate transaminase (SGPT) 
It is also called alanine aminotransferase (ALT). It catalyzes the transfer of an 
amino group from the amino acid alanine to oxoglutarate (keto acid) to produce 
glutamate. SGPT is a good indicator of hepatocellular injury because its major 
source is of hepatic origin, though it is widely found in variety of tissues. 
Elevated levels are found in hepatitis, cirrhosis, and obstructive jaundice (Hall, 
1992). 
B. Serum glutamate oxaloacetate transaminase (SGOT) 
It is also referred to aspartate aminotransferase (AST). It catalyzes the transfer 
of an amino group from the amino acid aspartate to oxoglutarate (keto acid) to 
form glutamate. SGOT is a cytoplasmic and mitochondrial isoenzyme and is 
widely distributed throughout body tissues with significant amounts in the heart 
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and liver (Wilkinson, 1976). Lesser amounts are found in skeletal muscle, 
kidneys, pancreas, spleen, lungs and brain. An increase in SGOT is found with 
hepatitis, liver necrosis, cirrhosis and liver metastasis (Sacks and Lanchantin, 
1960). 
C. Alkaline phosphatase (AP) 
AP is a group of phosphatases with alkaline working pH. Their distribution is 
ubiquitous including liver, bones, placenta and intestine. Their serum levels are 
of interest in the diagnosis of hepatobiliary disorders and bone disease 
associated with increased osteoblastic activity (Kachmar and Moss, 1976). 
D. Gamma-glutamyl transferase (y-GT) 
y-GT is one of a large group of enzymes known as peptidases. It catalyzes the 
transfer of y-glutamyl groups from peptides or peptide-like compounds to an 
acceptor peptide molecule. The major source of the enzyme present in serum is 
of hepatic origin, though its highest level is in renal tissue. Elevated levels of 
y-GT are associated with hepatobiliary and pancreatic disorders. It is a more 
sensitive indicator than AP of hepatobiliary disease, particularly for cirrhosis, 
metastatic Ca and hepatic infiltrations (Mayne et al, 1994). 
For enzymes, the common unit used is the "International Unit (lU)". One lU is 
equivalent to the quantity of enzyme that will catalyse the conversion of 1 jimol of 
substrate per min under specified conditions. 
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2.1.3.2 Other serum analytes 
A. Blood urea nitrogen (BUN) 
Urea is synthesized in the liver from ammonia which is produced as a result of 
the deamination of amino acids. The determination of urea nitrogen level in 
serum indicates the liver and kidney functions. The decrease of BUN level in 
serum is associated with nephritis, acute liver destruction, amyloidosis and 
pregnancy. The increase of BUN level is encountered with acute and chronic 
nephritis, intestinal and urinary obstruction, uremia, metallic poisoning, 
pneumonia, cardiac failure and peritonitis (Sampson et al., 1980). 
B. Creatinine 
Creatinine is a protein produced by the normal breakdown of muscle and 
released into the blood. The amount produced is relatively stable in a given 
person or animal. The creatinine level in the serum is therefore determined by 
the rate it is being removed, which is roughly a measure of the kidney function. 
If kidney function fails, the creatinine level will rise. The rise in level indicates 
the possibility of acute tubular necrosis, glomerulonephritis, renal failure, etc. 
Creatinine clearance is technically the amount of blood that is creatinine-cleared 
per time period (Bleiler and Schedl, 1962). 
C. Serum total protein 
Serum total protein measurements can reflect nutritional state, kidney disease, 
liver disease, and many other conditions. If total protein is abnormal, further 
tests must be performed to identify which protein fraction, and then which 
specific protein, is abnormal. Greater-than-normal levels may indicate chronic 
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inflammation or infection, multiple myeloma. Lower-than-normal levels may indicate 
bums (extensive), glomerulonephritis, hemorrhage, liver disease, malabsorption 
(inadequate absorption of nutrients from the intestinal tract), and malnutrition 
(Ringler and Dabich, 1979). 
D. Serum Glucose 
The diagnosis and management of hyperglycemia and hypoglycemia depends 
on the accurate estimation of glucose. Hyperglycemia may occur as a result of 
diabetes mellitus, in patients receiving intravenous glucose fluids, during severe 
stress and cerebrovascular accidents; while hypoglycemia may be the result of 
an insulinoma, insulin administration, inborn error of carbohydrate metabolism 
or fasting (Zilva and Pannall, 1979). 
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Table 2.1. Summary of the serum analytes used in short-term and sub-chronic 
experiments. 
Study area Analytes Origins 盜 Implicaticm of changes 
Elevation — hepatitis, cirrhosis and 
SGPT Hepatic cells . 
obstructive jaundice 
TT . Widely distributed 
Hepatic 
SGOT throughout body Elevation — hepatitis, cirrhosis, 
tissues, significant in liver necrosis and liver metastasis 
heart and liver 
Elevation - hepatobiliary, 
Peptidases, highest 
myocardial and pancreatic 
y-GT level in renal tissue, 
disorders; heavy consumption of 
hepatic origin 
alcohol; diabetics 
Decrease — nephritis, acute liver 
Hepatic, Renal destruction, amyloidosis. 
Deamination in liver, Elevation - acute and chronic 
BUN removed in urine nephritis, intestinal and urinary 
obstruction, uremia, metallic 
poisoning, pneumonia, Addison's 
Disease, peritonitis, cardiac failure 
• Concentrated in liver, Elevation - hepatobiliary disorders, 
Hepatobiliary, 八卩 bone and bile ducts bone disease associated with 
increased osteoblastic activity 
Elevation - acute tubular necrosis, 
Creatinine Muscles, blood, urine 
glomerulonephritis, renal failure 
Elevation - chronic inflammation 
or infection, multiple myeloma 
Renal . 
Serum total Decrease - bums (extensive), 
Albumin, globulin 
protein glomerulonephritis, hemorrhage, 
liver disease, malabsorption, 
malnutrition 
Elevation - diabetes, severe stress, 
Hyperglycemia, Serum Absorbed from diet, cerebrovascular accidents, 
hypoglycemia glucose balanced by insulin Decrease - insulinoma, error of 
carbohydrate metabolism 
Source of information: Ringler and Dabich, 1979; Hoffmann et al.’ 1999 
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2.1.4 Histopathological study 
Gross examination on the color and appearance of the liver can often indicate 
the nature of toxicity such as fatty liver or cirrhosis. The organ weight is a very 
sensitive indicator of effect on the liver. Liver weight has been shown in certain cases 
to be the most sensitive criterion of toxicity. For example, 
7-Acetyl-1,1,3,4,4,6-hexamethul-1,2,3,4-tetrahydronaphthalene (AHTN), a fragrance 
material was found to significantly increase the relative liver weight at a dose level 
that cause no histologic changes (Api et al, 2004). 
Light microscopy can detect a variety of histologic abnormalities, for instance, 
fatty liver, necrosis, and cirrhosis. 
A. Fatty liver — the abnormal accumulation of fat in hepatocytes and at the same 
time there is a decrease in plasma lipids and lipoproteins. Toxicants can cause 
lipid accumulation in the liver by different mechanisms. Lipid accumulation is 
related to disturbances in either the synthesis or the secretion of lipoproteins. 
Excess lipid can result from an oversupply of free fatty acids from adipose 
tissues or, more commonly, from impaired release of triglycerides (very low 
density lipoprotein, VLDL) from the liver into the plasma (Hodgson and Levi, 
2004). 
B. Cell necrosis - a degenerative process leading to cell death. Cell death occurs 
along with rupture of the plasma membrane, and is preceded by a number of 
morphologic changes such as cytoplasmic edema and organelles destruction 
which can be revealed under electronic microscopy. Biochemical events that 
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may lead to these changes include binding of reactive metabolites to proteins 
and unsaturated lipids disturbance of cellular Ca^ "" homeostasis, interference 
with metabolic pathways and inhibition of protein synthesis (Hodgson and Levi, > 
2004). 
C. Cirrhosis - a progressive disease that is characterized by the deposition of 
collagen. In most cases cirrhosis results from chronic chemical injury. The 
accumulation of fibrous material causes severe restriction in blood flow and in 
the normal metabolic and detoxication processes of liver (Hodgson and Levi, 
2004). 
It has been found that CCI4 induced histopathologic changes in the liver of rats 
at 0.0125 ml/kg body wt., but changes in liver weight and serum enzyme levels 
occurred only at a dose of 0.025 ml/kg body wt. (Korsrud et al., 1972). 
2.1.5 Acute toxicity 
Acute toxicity is the adverse effects produced by a substance when it is 
administered in one or more doses within 24 hours (OECD, 1987). The common 
usage of the term 'acute' in toxicology is as a descriptor of exposure rather than 
response. The results from acute toxicity test can help in assessing the toxic potential, 
extrapolating the safety consumption level for human beings, and providing useful 
information in the design of long-term toxicity test. Depending on the results of acute 
toxicity test, short-term and subchronic tests were designed to emphasize on possible 
abnormality found. 
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In toxicology, health risk assessment is in essence based on only two aspects: 
dose (amount per weight or volume) and effect (response, including underlying 
mechanisms). The relationship between dose of the chemical administered and the 
resulting response is established by exposing groups of organisms to various 
concentrations of the chemical (Leblanc, 2004). All substances are toxic, while each 
of them has a threshold dose at and below which no effect will occur. This is the 'no 
observable adverse effect level, (NOAEL). NOAEL is the greatest concentration or 
amount of a substance, found by experiment or observation, which causes no 
detectable adverse alteration of morphology, functional capacity, growth, 
development, or life span of the target organism under defined conditions of 
exposure (lUPAC, 1993). The NOAEL is the key datum obtained from the study of 
the dose-response relationship. The NOAEL is commonly produced in studies with 
experimental animals, in which several doses of a substance are tested using animals 
ranging from clearly toxic doses down to the NOAEL. Sometimes there is 
insufficient data to arrive at a NOAEL, and a LOAEL (lowest observed adverse 
effect level) is derived (Baynes, 2004). It is assumed that the NOAEL in animals is 
the same as that in humans (Sadler and Saltmarsh, 1998; Hodgson and Levi, 2004). 
The possible intra- and interspecies differences are overcome by multiplying the 
NOAEL by a safety factor (SF), resulting from the acceptable daily intake (ADI) 
which is a potentially safe level for human exposure (Figure 2.2) (Sadler and 
Saltmarsh, 1998). 
22 
i d X ^ O t o x i c l e v e l s 
g d l S o l o a e l 
T3 
NOAEL = A NOAEL 
(man, assumed) 
I * safety factor 
， (e.g. 10 X 10 = 100) 
^ ADI 
Fig. 2.2 Extrapolation of animal toxicity data towards safe levels for humans. *The 
safety factor (10 x 10) was to account for interspecies (rats to humans) and 
intraspecies (humans to humans) variation. (Adapted from Sadler and Saltmarsh, 
1998) 
In the present research, oral administration was selected as this is the common 
route of consumption. S.D. rats were used because of their manipulable size and their 
similarity of biotransformation system to that of human (Gill et al., 1989; Semler et 
a l , 1992). Ptr sclerotium powder was incorporated into the diet which was then 
freely accessible to the animals. Then the amount of Ptr sclerotium consumed by 
each rats was recorded. The maximum dose of Ptr sclerotium consumed by rat 
without causing any harmful effect or mortality was determined. 
2.1.6 Sub-acute and sub-chronic toxicity 
Short-term (sub-acute) and sub-chronic toxicity studies with rodents are 
generally conducted for 14 or 28 days (one month) and 90 days (3 months), 
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respectively. Results of these studies 1) can help predicting appropriate doses of the 
test substance for future chronic toxicity studies, 2) can be used to determine 
NOAELs for some toxicological endpoints, and 3) allow future studies in rodents to ‘ 
be designed with special emphasis on identified target organs (FDA, 2000). 
The common consumption of Ptr sclerotium is usually not high in one meal. 
Rather, people consume it repeatedly as a part of the meals during their life. Thus, 
after determining the NOAEL, the effect of sub-acute and sub-chronic consumption 
of Ptr sclerotia were evaluated. 
Three diet groups: control, 5% and 20% Ptr sclerotia were set for the sub-acute 
and sub-chronic experiments. For the control diet，the AIN93G diet recommended as 
an appropriate diet for rat safety evaluation studies by the American Institute of 
Nutrition was used (Reeves et al., 1993). The AIN-93G diets prepared from purified 
ingredients (such as casein, sucrose, starch, and defined mineral and vitamin 
premixes), such that their composition was well defined chemically. Moreover, 
undesirable contaminants, like heavy metals and pesticide residues, and variation in 
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composition of the cereal-based diets may be avoided (Rader, 1989). This purified 
rodent diet is a useful mean in delivering test substances in food safety evaluation, 
since they may be altered to allow for the assessment of macronutrients, while 
continuing to provide all essential dietary components in balanced proportions 
(Borzelleca, 1992). Rats at growing stage 4weeks) were chosen for the 
experiments as they are more susceptible to toxic substances than mature ones. In 
mammals, birth initiates an increase in the activity of many hepatic enzymes, 
including those involved in xenobiotic metabolism. The ability of the liver to carry 
out monooxygenation reactions appears to be very low during gestation and to 
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increase after birth. Phase II reactions may also be age dependent. In the serum and 
liver of perinatal (period around the time of birth) rats, glutathione transferase is 
barely detectable, but increasing rapidly until adult level is reached at about 140 days 
(Rose and Hodgson, 2004). Other than gestation and lactation, the greatest nutrition 
demands under normal physiologic conditions at early post-weaning growth (Rogers, 
1979). Hence, any effect on the growth of the rats at this stage would be more easily 
detected. AIN-93G diet which targets for rats at growing stage was then chosen for 
this study (Lien et al., 2001). The estimated total energy of AIN-93G was 3766 
kcal/kg diet which was based on the standard physiological fuel values for protein, 
fat, and carbohydrate to be 4，9 and 4 kcal/g, respectively (Reeves et al, 1993). Diet 
fed to rapidly growing weanling rat requires DE density of at least 3 kcal/g (Peterson 
and Baumgardt, 1971a and 1971b). 
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2.1.7 Objectives 
Investigations of the potential hepatoprotective effect and the safety evaluation 
of Ptr sclerotium are equally important. The safety evaluation was carried out prior to 
the hepatoprotective study, as it would give fundamental information to support for 
its potential use as functional food. 
As detailed toxicological data of Ptr sclerotium has not been reported yet, the 
first objective in this study is to investigate the toxicity of Ptr sclerotia in terms of 
acute, sub-acute and sub-chronic toxicity using male S.D. rats as the animal model. 
Death, reduced body weight and clinical symptoms in the animals fed with Ptr 
sclerotium were monitored. General toxicity was determined by biochemical assays 
on serum collected from the rats. The parameters tested include serum glutamate 
pyruvate transaminase (SGPT), serum glutamate oxaloacetate transaminase (SGOT), 
alkaline phosphatase (AP)，gamma-glutamyl transferase (y-GT), creatinine, blood 
urea nitrogen (BUN), serum total protein and serum glucose. Different organs per 
body weight were measured for liver, kidneys, spleen, the whole caecum and caecum 
without its content. Light microscopy, which provides evidence of necrosis or 
steatosis, was used to evaluate the possible changes in the animal's liver. The detailed 
reasons and the underlying principles of the experimental designs were already 
mentioned. 
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2.2 Materials and Methods 
/ 
2.2.1 Sample materials and chemicals 
Sclerotia of Pleurotus tuber-regium (Ptr) were cultivated by the Sanming 
Mycological Institute in Fuijan, China. The dark brown skin of the sclerotia was 
removed and the white tissue was cut into small pieces. The pieces were ground into 
powder with particle diameter not larger than 0.5 mm in a dry electric mill. The Ptr 
powder was stored in a desiccator until use. 
Six and half grams of anhydrous sodium phosphate, dibasic (Sigma-Aldrich, St. 
Louis, MO, USA), 4.0g monohydrated sodium di-hydrogen phosphate 
(Sigma-Aldrich, St. Louis, MO, USA) and 100ml of formaldehyde solution 
(Sigma-Aldrich, St. Louis, MO, USA) were dissolved in 900ml distilled water to 
make up 1000ml of 10% buffered formalin solution. A 0.9% saline solution was 
prepared by dissolving 9g of sodium chloride salt in 1000ml of distilled water. The 
solution was used for the washing of organs, dissecting apparatus or the dilution of 
serum. 
2.2.2 Acute toxicity test 
2.2.2.1 Diet and animals 
The sclerotial diet was prepared by mixing Ptr sclerotium powder with the 
rodent chows (PMI Feeds Inc., St. Louis, MO., U.S.A.) at a 2:1 ratio by weight 
(66.7% Ptr sclerotium by weight) or at 3:1 ratio (75% Ptr sclerotium by weight). The 
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powder was mixed thoroughly and water was added to assist molding into rod-liked 
structure resembling normal rodent chows. The moisturized Ptr sclerotia diet was 
then dried in a 60�C oven overnight so that the dry weight of diet consumed by the 
animals could be measured. The control diet were prepared by mixing cellulose 
(Sigma-Aldrich, St. Louis, MO, USA) with rodent chows at the ratios of 2:1 and 3:1 
by weight for the 2 separate experiment. 
Sprague-Dawley rats, weighing 260-280g were obtained from the Laboratory 
Animals Service Centre, The Chinese University of Hong Kong. They were housed 
in a controlled-environment of 18-20 humidity 54-56% with 12-hour light-dark 
cycle and were supplied with standard rodent chows and tap water ad libitum. 
2.2.2.2 Experimental design 
I 
Caged individually, 8 rats were acclimilated for 5 days and allowed to access 
standard rodent chows and tap water ad libitum. After acclimilation, at time 0, 6 rats 
were fed with the sclerotial diet which represented the sclerotial group. The 
1 1 1 
remaining 2 rats represented the control group and were fed with standard rodent 
chows. Both groups were allowed to access the corresponding diet freely for 24 h. At 
the 24th h, the amount of diet consumed by the rats was weighed and recorded. 
Fasting was carried out for 12 h before the blood was withdrawn from all of the 8 
rats for biochemical assays. The overview of the experimental procedures is shown 
in figure 2.3. Standard rodent chows was then given to all of the rats until day 4, 
when all of the rats were terminated. The whole livers were excised for weighing and 
histopathological study. Any clinical symptoms or deaths were monitored and 
recorded during the experiment. 
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Fig. 2.3 The experimental procedures of acute toxicity test. 
2.2.2.3 Calculation of sclerotium intake dose 
As Ptr sclerotium powder was mixed with normal rodent diet at 2:1 ratio，the 
sclerotial intake dosage (g/kg body wt.) was calculated by the equations below: 
Sclerotium consumption (g) = amount of diet consumed x sclerotium % in diet 
=amount of diet consumed x 66.67 % 
Sclerotium intake dosage (g/kg body wt.) 
=(amount of diet consumed x 66.67 %) / body weight of rat 
The sclerotium intake dose of 75% sclerotial diet was calculated as the same as 
above except 75% (instead of 66.67%) was used to multiply with the amount of diet 
consumed. 
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2.2.2.4 Biochemical assays 
The rats were anaesthetized with diethyl ether (Sigma-Aldrich, St. Louis, MO, 
USA) 12 h after the fasting period. About 5ml of blood was withdrawn by heart 
puncture with sterile disposable syringes and transferred to a 15ml centrifuge tube. 
Serum was separated from the whole blood by centrifugation at 3000 rpm for 15 min 
at 40C. Serum was then separated from the cells immediately to avoid any 
interference caused by haemolysis, as glutamate oxaloacetate transaminase (GOT) in 
red blood cells is roughly 5 times to that of serum. The serum glutamate pyruvate 
transaminase (SGPT) and serum glutamate oxaloacetate transaminase (SGOT) level 
of each rat were estimated using the Stanbio GPT (Liqui-UV®) and GOT (Liqui-UV®) 
kits. All the rats were terminated in a glass jar supplied with carbon dioxide. 
One millilitre of the working reagent for GPT and GOT prepared by mixing 5 
parts of the buffer (Reagent 1) to 1 part of the enzyme solution (Reagent 2) was 
pipetted into a cuvette and warmed to l^TC for 3 min. An aliquot of serum (0.10ml) 
was added to the cuvette and mixed gently. After Imin of incubation, the absorbance 
was recorded. The cuvette of reacting solution was taken out and the absorbance was 
recorded again at 2 and 3 min. The average absorbance per minute (AA/Min) was 
determined. 
Calculation was based on the ‘‘absorptivity micromolar extinction coefficient" 
of NADH at 340 nm (0.0063). A unit per liter (U/L) of GPT is that amount of 
enzyme which oxidizes one jiimol/L of NADH per minute. 
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SGPT (U/L) = [(A A/Min)/Absorptivity] x (Total volume/Sample volume) 
=[(AA/Min)/0.0063] x (1.10/0.10) 
= (AA/Min)x 1746 ‘ 
For SGOT, the preparation of working reagent (Reagent 1 and 2), experimental 
protocol and the calculation were the same as that of SGPT. 
2.2.2.5 Histopathological examination 
After termination, the whole liver of each rat were dissected from the body and 
washed with 0.9% saline. The liver was dried by a tissue paper and weighed in an 
electronic balance. 
A portion of the median lobe of the liver was sliced and fixed in 10% buffered 
formalin solution for 24 to 48 h and dehydrated through an ascending series of 
different percentages of ethanol and washed in xylene. After embedding in paraffin 
(melting point 56-58 °C), the liver specimens were cut at 5 to 7 jiim thickness by a 
microtome and then stained with Mayer's hematoxylin and eosin (H&E) for 
histopathological examination under light microscope. 
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2.2.3 Sub-acute and sub-chronic toxicity tests 
2.2.3.1 Diet Preparation 
The American Institute of Nutrition Rodent Diet, AIN-93G was used as the 
control diet for the sub-acute and subchronic experiments. Ptr sclerotial diets were 
prepared according to the formulae shown below. 
The diet was fed in solid form resembling the structure of common rodent 
chows in the short-term toxicity test, while powder form was given in the subchronic 
test. 
2.2.3.2 Experimental design 
The sub-acute toxicity experiment consisted of feeding rats with 3 diet groups, 
the control, the 5% sclerotial, and the 20% sclerotial prepared according to the 
AIN-93G diet (table 2.2). In each group, 4 male and 4 female weanling 
Sprague-Dawley rats at about 4 weeks obtained from the Laboratory Animals Service 
Centre, The Chinese University of Hong Kong. They were caged individually in a 
metabolic cage in a controlled-environment of 18-20。(：，humidity 54-56% with 
12-hour light-dark cycle and were supplied with standard rodent chows and tap water 
ad libitum. Then animals were acclimatized individually in metabolic cages for 5 
days before the start of the experiments. The faeces and urine were collected at the 
bottom of each metabolic cage. The picture of a metabolic cage is shown in figure 
2.4. During the experiment, any clinical symptoms or abnormal behavior were 
recorded. At the end of the 30 '^' day, blood and organs were collected from the rats 
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for biochemical assays and histopathological examinations after fasting for 12 h. 
The experimental design of sub-chronic toxicity test was carried out as the same 
as the sub-acute toxicity test using 5% and 20% Ptr sclerotial diets except that the 
rats were fed for 90 days. 
For the short term 30 day toxicity test, the body weight of each rat was recorded 
on the first day, day and the last day (30^^ day) of the feeding period. While for 
the sub-chronic test, data were recorded on the first day, day, day and the 




Fig. 2.4 Metabolic cage for accommodation of rats in sub-acute and sub-chronic 
experiments. 
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Table 2.2. The diet composition (g/kg) of sub-acute (30-day) and sub-chronic 
(90-day) toxicity tests using weanling S. D. rats modified from AIN-93G 
formulation. 
Control diet Sclerotial diet 
AIN-93G* 5% 20% 30% 
Cornstarch 397 397 247 147 
Casein 200 200 200 200 
Dextrinized cornstarch 132 132 132 132 
Sucrose 100 100 100 100 
Soybean oil 70 70 70 70 
Cellulose 50 - - -
Mineral mix 35 35 35 35 
Vitamin mix 10 10 10 10 
L-cystine 3 3 3 3 
Choline bitartrate 2.5 2.5 2.5 2.5 
Tert-butylhydroquinone 0.014 0.014 0.014 0.014 
Ptr sclerotium - 50 200 300 
Notes: The diet composition consists of, in descending order by weight, cornstarch 
(Kingsford's, Hong Kong), casein (Sigma-Aldrich, St. Louis, MO, USA), dextrinized 
cornstarch (Sigma-Aldrich, St. Louis, MO, USA), sucrose (sugar, Taikoo, South 
Korea), soybean oil (Sigma-Aldrich, St. Louis，MO, USA), fiber (cellulose, 
Sigma-Aldrich, St. Louis, MO, USA), mineral mix (Sigma-Aldrich, St. Louis, MO, 
USA), vitamin mix (Harlan Teklad, USA), L-cystine, choline bitartrate 
(Sigma-Aldrich, St. Louis, MO, USA), and tert-butylhydroquinone (Sigma-Aldrich, 
St. Louis, MO, USA). 
*American Institution of Nutrition Diet for growth, pregnancy and lactational phases 
of rodents. (Philip G, et al, 1993) 
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2.2.3.3 Biochemical assays 
The rats were anaesthetized with diethyl ether 12 h after the fasting period. 
About 5ml of blood was withdrawn by heart puncture with sterile disposable 
syringes. Serum was separated from the whole blood by centrifugation at 3000 rpm 
for 15 min at 4�C. Serum was then separated from the cells immediately to avoid any 
interference caused by haemolysis. The levels of the serum analytes, included 
alkaline phosphatase (AP), creatinine, gamma-glutamyl transferase (y-GT), glucose 
level, SGOT, SGPT, total protein, and blood urea nitrogen (BUN) were determined 
using the Stanbio kits. The protocol of each kit was stated below while that of SGPT 
and SGOT was the same as section 2.2.2.4. 
A. Alkaline phosphatase (AP) 
The reagent was reconstituted by adding 15ml distilled water to the vial of 
substrate. The vial was swirled gently to dissolve the contents. 
One millilitre of Alkaline Phosphatase Reagent was dispensed into a cuvette 
prewarmed in 37°C water bath. An aliquot of each serum sample (0.025 ml) was 
added to the cuvette with reagent and the solution was mixed by pipetting up and 
down. The reaction mixture was incubated for 60 sec at 37°C. Meanwhile, the 
wavelength of spectrophotometer was set at 405nm and water was used to set zero. 
The increase in absorbance was recorded at 60 sec intervals for 3 min. The cuvette 
was incubated at 37®C between readings. The average absorbance difference per 
minute was calculated (AA/Min). 
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Values were derived based on the p-nitrophenol “absorptivity micromolar 
extinction coefficient” at 405 nm (0.01875). A unit per liter (U/L) of AP is that 
amount of enzyme which produces one mmol/L of p-nitrophenol per minute. 
AP (U/L) = [(A A/Min)/Absorptivity] x (Total volume/Sample volume) 
=[(A A/Min)/0.01875] x (1.025/0.025) 
=(A A/Min)x2187 
B. Creatinine 
The reagent was prepared by mixing 1 part of Creatinine Acid and 1 part of 
Creatinine Base Reagent. The spectrophotometer was zeroed with deionized water at 
SlOnm. 
One millilitre of the working reagent was pipetted into a cuvette prewarmed at i 
37OC. An aliquot of standard (0.050ml) (from kit) was transferred to the cuvette with 
working reagent and mixed by pipetting up and down. The reaction mixture was 
incubated for 20 sec and then the absorbance (A!) was recorded. After exactly 60 sec, 
the absorbance was recorded again as A2. The absorbance (AA) was calculated by 
substracting A2 — A卜 The above procedures were repeated for serum samples. The 
results were calculated by comparing the absorbance change (AA) of the serum 
sample (Au) with that of a standard (As). 
Serum Creatinine (mg/dL) = (A Au / AAs) x 5 
where 5 is the concentration of the standard (mg/dL). 
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C. Gamma-glutamyl transferase (y-GT) 
The reagent was prepared by adding 15ml of deionized water to the vial of ‘ 
reagent. The vial was swirled gently to dissolve the contents. 
For each sample, 1.0ml reconstituted reagent was added to a cuvette and 
warmed to 37�C for 5 min. An aliquot of the serum sample (0.05ml) was added to the 
cuvette and mixed gently by pipetting up and down. The reaction mixture was 
incubated for 30 sec. The spectrometer was zeroed at 405nm with distilled water. The 
increase in absorbance was recorded at 60 sec intervals for 3 min. The cuvette was 
incubated at 37°C between readings. The average absorbance difference per minute 
was calculated (AA/Min). 
Values were derived based on the "absorptivity micromolar extinction 
coefficient,, of p-nitroaniline at 405 nm (0.0099). A unit per liter (U/L of y-GT 
activity is that amount of enzyme which produces one jiimol/L of p-nitroaniline per 
minute. 
y-GT (U/L) = [(A A/Min)/Absorptivity] x (Total volume/Sample volume) 
=[(AA/Min)/0.0099] x (1.05/0.05) 
二（A A/Min)x2121 
D. Serum glucose 
Hexokinase reagent (1ml) was pipetted into cuvettes which were incubated at 
37°C. The spectrophotometer was set zero with the hexokinase reagent at 340nm. An 
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aliquot of standard (0.01ml) was pipetted into the cuvette and mixed by pipetting up 
and down. The above step was repeated for the serum samples. Then the cuvettes 
were incubated for 30 min before the measurement of absorbances. The results were ‘ 
calculated by the equation below: 
Glucose (mg/dL) = (Au / As) x 100 
where Au and As were the absorbance values of serum sample with unknown 
value and standard, respectively. The concentration of standard was 100 mg/dL. 
E. Total protein 
The total protein reagent (1ml) was pipetted into cuvettes which were incubated 
at room temperature. The spectrophotometer was set zero with the reagent at 550nm. 
An aliquot of standard (0.01ml) was pipetted into the cuvette and mixed by pipetting 
up and down. The above step was repeated for the serum samples. Then the cuvettes 
were incubated for at least 5min before the measurement of absorbances. The results 
were calculated by the equation below: 
Serum total protein (g/dL) = (Au / As) x 10 
where Au and As were the absorbance values of serum sample with unknown 
value and standard, respectively. The concentration of standard was 10 g/dL. 
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F. Blood urea nitrogen (BUN) 
The working reagent was prepared by mixing 5 parts of Buffer (Rl) with 1 part 
of Enzyme (R2). The reagent was allowed to stand for at least 30 min at room 
temperature ( 1 5 - 2 5 before use. The spectrophotometer was zeroed at 340nm 
with distilled water. 
One milliliter of working reagent was added to a cuvette which was prewarmed 
to 3TC. Then 0.010ml serum was added to the cuvette and mixed gently. After 
exactly 30 sec’ the absorbance was recorded as Ai. At exactly 60 sec after Ai, the 
absorbance was recorded again as A!. The change in absorbance (AA) was calculated 
by subtracting (A! — A � ) . The above steps were repeated for the rest of samples. 
Serum BUN was derived by comparing the absorbance change of the sample 
with that of standard. 
Serum BUN (mg/dL) = (Au / As) x 30 
where Au and As were the absorbance values of serum sample with unknown 
value and standard, respectively. The concentration of standard was 30 mg/dL. 
2.2.3.4 Organ weight 
The whole organ of liver, kidneys，spleen, and caecum of each rat were 
dissected from the body and washed with 0.9% saline. The organs were dried by a 
tissue paper and weighed in an electronic balance. The caecum with the inside 
4 0 
content removed were also measured. The ratios of organ per body weight were 
calculated for each organ. 
2.2.3.5 Histopathological examination 
The portion of liver for each rat was fixed, cut and stained in the same way as 
section 2.2.2.5. 
2.2.4 Statistical analyses 
The data in the acute toxicity test was analyzed by Student's /-test. The value of 
the mean ± S.D. of liver per body weight, SGPT and SGOT levels of the control and 
treatment groups were compared by Student's /-test. Differences were considered 
significant \ f p < 0.05. 
For sub-acute and sub-chronic toxicity tests, the mean 土 S.D. of the serum 
analyte levels, body weights and organ weight per body weight ratios were compared 
among the groups using one-way ANOVA. Once significant differences had been 
detected (p < 0.05), Tukey HSD test was used as a post-ANOVA pair-wise 
comparison for the mean value among groups. 
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2.3 Results and Discussion 
2.3.1 Acute toxicity test 
At the beginning of the research, there were a few trials to feed the rat with Ptr 
sclerotium by gavage in the acute toxicity tests. Ptr sclerotium was mixed with 
different proportions of water in order to be delivered directly to the stomach of the 
rat by gavage. It was found that a sclerotium-to-water ratio of 0.7:1 weight by 
volume was required in order to avoid blocking of gavage tube. On the other hand, 
because of the size limitation of the stomach of rat, the amount of sclerotium fed in 
this way would be rather low (< 17 g/kg body wt.). 
Assuming 7 g of the sclerotium mixture could be fed to a 250 g rat in a day, 
daily sclerotium consumed ； 
= ( 7 g X proportion of sclerotium in the diet) / kg body wt. | 
= { 7 g x [0 .7 / (1 +0.7)]} / 0.25 kg 
=11.54 g/kg body wt. 
In acute toxicity test, NOAEL determined in animal species is equal to that for 
human. For a 70 kg human，11.54 g/kg equals to a safe daily intake of 807 g of Ptr 
sclerotium. It has been known that Ptr sclerotium is commonly consumed by people, 
which means a higher amount should be tested for an acute toxicity test. 
Force feeding has an advantage in controlling the amount of substance delivered 
to the rats but it was not feasible for the Ptr sclerotium in this case. Therefore, 
another tested method was to feed the rat with small pieces of raw sclerotium. 
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However, the rats were unwilling to consume the sclerotium which might due to its 
texture or the odour according to experimental observations. To encourage the 
consumption of the rats, normal rodent chows were used to mix with the sclerotial 
powder. As more than 80% of the sclerotium is non-starch polysaccharides (Cheung 
and Lee, 1998), cellulose were used as substitute of Ptr sclerotium in the control diet. 
From observation and checking of food consumption, the rats had no preference on 
either the control or Ptr sclerotial diets in terms of food intake (data not shown). 
Therefore, in the acute toxicity tests, any differences occurred would be due to the 
effect of the sclerotium. 
2.3.1.1 Food consumption 
I 
The amount of diet consumption and the body weight of rats in each group were ‘ 
i 1 
shown in table 2.3. There were no significant differences found between different 
j 
diet groups which provided an equal baseline for the following comparisons. The | 
range of Ptr sclerotium intake dose of rats in the 66.67% sclerotial diet group was 
52.39 - 59.65 g/kg body wt., while that of the 75% sclerotial diet group was 65.25 — 
80.27 g/kg body wt.. 
There were no abnormal clinical symptoms observed and also no death of the 
animals was found in both the control and Ptr sclerotial diet groups (66.67% and 
75% sclerotial diet) during the 4 d experimental period. 
The amount of Ptr sclerotium consumed by the rats in both treatment groups 
(66.67% and 75% Ptr sclerotial diets) was relatively high with reference to human. 
For a human adult with normal body weight, say 70 kg, the relative consumption of 
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Ptr sclerotium would be 70 kg x 59.65 g/kg body wt. (highest dose in 66.67% Ptr 
sclerotial diet) 二 4176 g taken within 24 h. A total amount of 4 kg is rarely the 
amount of Ptr sclerotium that can be consumed by human beings in a day. 
2.3.1.2 Serum transaminase activities 
Serum GPT and GOT levels of the animals from Ptr sclerotial diet group were 
not significantly different {p > 0.05) from those of the control group and lower than 
the upper reference limits (SGPT: 30.2 lU/L; SCOT: 80.8 lU/L) (Semler et al, 1992) 
showing no adverse effect to the liver in both experiments (Table 2.4). 
Acute toxicity of a chemical can be measured by its dose-response curve. The ； 
dose-response relationship provides an estimation of the relationship between the 丨 
！ 
dose of a substance (sclerotium intake in this case) and incidence of effects in a 
！ 
population (Baynes, 2004). Toxicological data can be defined as quantal, continuous, 
or graded. Biological indicators such as organ weight and serum enzyme activities : 
I 
are continuous data which can be used to construct a dose-response curve (Dourson, ‘ 
1986). Since the rats were allowed to access the diet freely, their intake dosages 
could not be controlled. Nonetheless, these data may help in determining if there is a 
trend of response with the intake dosage. As Ptr sclerotium is widely accepted as 
edible, mortality was not expected and thus was not used in interpreting the adverse 
effect to the experimental animals. Thus, the serum transaminase levels were used to 
plot against the dietary intake of 66.67% and 75% sclerotial diet (Figure 2.5 and 2.6). 
From this plot, it can be concluded that there is no correlation between the sclerotium 
intake dosage and serum transaminase levels evaluated at the range of 52.39 - 80.26 
g/kg body wt. of Ptr sclerotium consumed. The correlation factors, r^ in all curves 
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were smaller than 0.1 indicating a very low relationship between the effect produced 
by Ptr sclerotial diet to the liver of the rats and the level of sclerotium intake in the 
experiments. 
2.3.1.3 Histopathology 
The necropsy and gross examination showed that the appearances, color and 
shape of on the main internal organs especially the liver were normal in rats from 
both Ptr sclerotial diet and control groups. The values of liver per body weight of the 
rats in both sclerotial diet groups were not significantly different from those of the 
control (p > 0.05) (Table 2.4). Consistent results were obtained in histopathological 
examinations on the livers of rats which also revealed normal hepatic cells and 
architectures in rats from control and sclerotial diet groups under light microscope ‘ 
！ 
(Figure 2.7). Clear sinusoid pattern could be found in healthy liver sections (Figure 
2.7a and b). Comparison made with those of rats treated with CCI4 clearly showed I 
severe centrilobular necrosis and fatty accumulation (Figure 2.7c). The biochemical 
and histopathological studies indicated that the acute consumption of 66.67% and ‘ 
75% Ptr sclerotial diets did not associate with any adverse effect to rats. 
2.3.1.4 NOAEL 
NOAEL of rat is equal to NOAEL of humans. The NOAEL obtained in 
experiments is then used to calculate the ADI (Sadler and Saltmarsh, 1998; Hodgson 
and Levi, 2004). In the present research，there were no adverse effects observed in 
rats in terms of clinical symptoms, biochemical assays, and histopathological studies 
in all Ptr sclerotial diet dosages. The highest sclerotium dosage reached without 
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causing any adverse effects to the rat is 59.65 g/kg body wt. which was the NOAEL 
found in the first experiment with 66.67% sclerotial diet. The value, 80.27g/kg body 
wt. was the NOAEL in the second experiment with 75% sclerotial diet. In 
comparison, fructooligosaccharides (FOS), the inulin-type fructans with the degree 
of polymerization 3.5, fed to S.D. rats at 9 g/kg body wt. by gavage induced no 
deaths and abnormality in terms of body weight and clinical symptoms (Carabin and 
Flamm, 1999). If 100 is taken to be the safety factor, the ADI for human is 0.8027 
g/kg body wt. (NOAEL + 100). For a 70 kg person, 56.2 g (70 kg x 0.8027 g/kg 
body wt.) Ptr sclerotium (in which 80%, i.e. 45.0 g is dietary fiber) is safe for 
consumption in a day which is more than the U.S. recommended daily value (RDV) 
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Table 2.3. The body weight and diet consumption of rats fed with the control and 
sclerotial diets in acute toxicity test. 
r) 1 . 1 ^ ^ ” Sclerotium Body weight Daily diet . 
, � . … intake dose 
(g) consumption (g) 
(g^g) 
66.670/0 Control (n二2) 215 土 6 18.5 ±0.16 -
sclerotial 
66.67% Sclerotial ~ ‘ 
— diet (n二4) 221 ±11 18.6 ± 0.58 56.1 ±3.22 
'75% Control (n二2) 229 土 3 20.5 士 0.45 -
sclerotial 
. 75% Sclerotial — 
d i e t i : ) ± 2 22.1 土 1.87 72.8 土 5.71 
Values are means 土 S.D. statistically analyzed by Student's /-test, p < 0.05. 
Table 2.4. Serum transaminase levels and liver per body weight ratio of rats fed with 
the control normal diet and sclerotial diets in acute toxicity test. 
SGOT(IU/L) SGPT(IU/L) Liver per body 1 
weight (g/kg) 
66.670/0 Control (n=2) 70.96 士 4.34 18.98 士 2.60 30.25 士 5.26 
sclerotial 丨 
� . 66.67% Sclerotial 
diet (n=4) 75.32 ± 6.68 20.33 ± 1.87 32.20 ±7.17 
750/0 Control (n=2) 72.08 士 3.31 15.98 士 0.08 33.36 士 6.84 
sclerotial 
I 75% Sclerotial 
diet (n=4) 74.64 士 7.30 15.94 士 1.51 31.14 土 5.73 
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2.3.2 Sub-acute toxicity test 
2.3.2.1 Body weight gain 
It was observed that the animals fed the two Ptr sclerotial diets were healthy 
without showing any unusual behaviour during the 30-day study period. All of the 
rats gained weight with no significant differences (p > 0.05) found in growth 
between the control and the animals fed with different levels of Ptr sclerotial diets 
(Table 2.5). Stool from rats in the 20% sclerotial group were khaki (dull 
yellowish-brown) in colour while those in the control and 5% sclerotial groups were 
brown. 
One rat (female) from the control group and 4 rats (2 females, 2 males) from the 
| i 'I 
20% sclerotial diet group died following the first blood collection at the day of “ 
the experiment due to some technical errors. The mortality occurred was due to 
I " 
withdrawal of an excessive blood volume that was not related to the diets. All other ji 
animals survived throughout the feeding period. 丨; 
I 
Figure 2.8 showed the growth of rats fed with different diets. Rats from all the 
three groups gained in body weight at the end of the experiment. Figure 2.9 showed 
the percentage increase in the body weight of female and male rats from different 
diet groups. Male rats had higher body weight increase than female rats in each diet 
group but did not show significant differences (Student /-tests, p > 0.05) across each 
diet group. As shown in the figure 2.9, the standard deviations were relatively high. 
This could be explained by the large variations in the consumption pattern of the rats. 
It was probably due to errors in the estimation of food intake and substantial loss of 
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food. Some of them tended to grasp the pieces of chows from the container to the 
cage where the floor was net-like. As a result, once the rats tried to put down their 
food, it fell to the faeces collector and was wasted. This was not happened in all rats 
but only in some of them which could lose all the chows given within 30 min. After 
such observation, the rod-shaped food was cut into smaller pieces (about O.lg each) 
so as to avoid their intention to carry the food back to their "living place" and to 
minimize the loss. The situation was improved, yet sometimes these rats were fasted 
due to the lost and this was considered as the reason for their limited growth. 
Therefore, even within the same group, the body weight increase of rats varied to a 
certain extent. 
2.3.2.2 Biochemical assays 
All the mean levels of serum analytes and enzymes fell within the normal range 
of rats (Semler et al, 1992) (Table 2.5). There were no significant difference in the 
levels of plasma analytes between the control and sclerotial groups of rats except 
alkaline phosphatase (AP) and blood urea nitrogen (BUN) (Table 2.5). Rats fed with 
the 20% sclerotial diet had a significantly lower serum AP level {p < 0.05) than rats 
fed with the control and 5% sclerotial diets. A low AP level indicates food 
deprivation or lack of necessary nutrients in diet such as zinc and protein (Semler et 
a/.，1992). Rats from 5% sclerotial diet had a significantly lower (p < 0.05) BUN 
value (average 16.70 lU/L) than those from the control group (average 21.58 lU/L). 
The value of BUN of rats from 20% sclerotial diet was in between the control and 
5% sclerotial diet, showing no significant difference to both groups (p > 0.05). This 
suggested that the effect on BUN might not be directly proportional to dose intake of 
Ptr sclerotium in this percentage range. A lowered BUN value indicates the 
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possibilities of nephritis, acute liver destruction, or amyloidosis (Hoffmann et aL, 
1999). 
There was an increasing trend of serum glutamic pyruvic transaminase (SGPT) 
and creatinine level with the percentage of Ptr sclerotium intake, although there were 
no significant differences (p > 0.05) (Table 2.5). The serum glucose level was higher 
than the normal reference range (50 - 135 mg/dL) (Semler et aL, 1992) in all groups 
since there was no fasting the night before blood collection. Rats might consume 
food right before blood collection so that blood glucose level rose as a result of 
digestion and absorption of the carbohydrate. Serum glucose level decreased as the 
percentage of Ptr sclerotium in the diet increased, however the standard deviations 
were large so that no significant difference could be detected (p > 0.05). 
2-3.2.3 Organ per body weight and histopathology 
Figure 2.10 depicts the organ per body weight ratios of animals at the end of 
/ 
I 
30-day feeding. No adverse abnormal changes were observed in organ weight with f 
nil 
respect to body weight of rats fed with Ptr sclerotial diets in comparison to that with 
control diet. The liver and spleen per body weight of Ptr sclerotial diet groups were 
lower than that of the control group although there was no significant difference (p > 
0.05). There was an increasing trend of whole caecum per body weight with the 
increase of Ptr sclerotium percentage in the diet but there was no significant 
difference (p > 0.05). Observations of gross pathology made immediately after 
dissection on rats of all groups no apparent pathological abnormalities in the animals. 
Histopathological examination of the liver in the control and the sclerotial diets 
showed no differences (Figure 2.11). 
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2-3.2.4 Effects of Ptr sclerotial diets 
The sclerotium in 5% sclerotial diet, as mentioned above，completely 
substituted cellulose as dietary fiber in the diet. This allowed the comparison of 
possible difference between the substances in acting as dietary fiber. Results in figure 
2.10 and table 2.5 showed that the control and 5% sclerotial diet did not distinguish 
from each other in terms of organ per body weight ratios and biochemical assays 
except BUN. Liver destruction (as one of the possible implications of lower BUN 
level in rats fed with 5% Ptr sclerotial diet) was not supported by the 
histopathological study. Healthy hepatic structure was found in every rat in the 
control and 5% sclerotial group. Moreover, their liver per body weight ratios were 
statistically the same. Thus, the damage to liver caused by the Ptr sclerotium seemed 
to be low. The kidney per body weight ratio was also similar to that of rats from the 
I 
control group. Since renal histopathological study was not carried out, the conclusion 
of nephritis could not be drawn. Although the BUN levels of the control and 5% 
sclerotial group were significantly different, they were within the range in normal \ 
rats (Semler et al., 1992) suggesting that the 5% sclerotial diet induced no adverse 1 
effect to the hepatic and renal functions of the animals. 
For the 20% sclerotial diet, Ptr sclerotium substituted the whole fiber content as 
well as 37.74% of cornstarch in the diet by weight. This made the diet had a high 
fiber content which was assumed to be digested (fermented) by the bacteria in the rat 
caecum. In the biochemical, liver histopathologic and general anatomical studies, rats 
fed with the 20% sclerotial diet were as healthy as that from the control group. 
A definite conclusion could hardly be made on the above date as the variation of 
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food intake might have a great. Nonetheless, these observations and findings led to 
the improvements in the experimental design of the 90-day sub-chronic toxicity test 
(refer to 2.2.3). These improvements provided more precise and consistent results to 





Table 2.5. Values of serum analytes and body weight changes from rats fed with 
control or sc le ro t ia^e t s for 30 days sub-acute toxicity test. 
Control diet 5% sclerotial 20% sclerotial || Reference || 
_ _ _ (n=7) diet (n-8) || diet (n-4) range** 
士 82. 4 9 ± 2 1 . 9 5 ! 4 5 . 7 - 8 0 . 8 
GPT (lU/L) 土 7 . 3 6 4 24.16 士 3.139 17.5 - 3 0 . 2 
AP (lU/L) 167.8 土 6 1 . 5爿� 1 3 8 . 3 土 57.08a [77 .59 士 22.97b 56.8 — 128 
Y-GT (IU/L) 2.121 土 2.582 1.591 士 1.722 || 2.475 士 0.913 | | ！ ^ “ 
BUN (mg/dL) 21.58 土 3.61ia 16.70 士 2.660卜 17.88 士 4.01 l^b 
Creatinine | 
(mg/dL) 1.429 士 1.125 1.563 士 0.884 1.875 士 0.722 0 -20-0 .80 
Total Protein 
(g/dL) 6.384 ±0.623 6.080 土 0.738 6.713 士 0.753 4.70 一 8.15 丨 
Glucose (mg/dL) 376.0 士 79.93 370.5 士 59.06 311.0 士 108.4 5 0 - 135 
Body weight (g) 266.2 土 31.59 | 255.1 士 55.23 289.5 士 56.18 _ 
Body weight “ ‘ ‘ 
increase (0/0) | 40.03 士 12.61 | 19.84 土 16.63 34.73 士 11.11 | _ 
Data are means ± standard deviation. The mean values within the same column with !； 
different superscripts were significantly different (one-way ANOVA, Tukey p < ！ 
0.05). , , j 
*One International Unit (lU) is the amount of enzyme which can catalyze the •_ 
transformation of 1 j^mol substrate per minute. 
Reference ranges were normal or control values for rats (Semler et al., 1992). NA, 
data not available. 
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Fig. 2.8 Growth curve of rats fed with control, 5% or 20% sclerotial diets in a j 
30-day sub-acute toxicity test. 
7 0 ™ ^ ~ • — 丨 
• female 
妥 6 0 • 1 - — ^ 
一 T • male CD 
oo 1  
g 50 . . — — j 
1 4 0 i 
- t • • � l . f l 
； 1 。 一 ^ ^ B i 
control 5% 20% 
Diet group 
Fig. 2.9 Body weight increase of female and male rats from control, 5% or 20% 
sclerotial diet groups in a 30-day sub-acute toxicity test. 
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Fig. 2.10 Organ per body weight of rats fed with control, 5% or 20% sclerotial diets 





































































































































































2.3.3 Sub-chronic toxicity test 
No abnormal behaviours were observed during the 90-day experimental period. 
Stool from rats in the 20% sclerotial group were khaki in colour while those in the 
control and 5% group were brown. 
Two male rats from the control group and 1 male rat from the 5% sclerotial diet 
group died following the first blood collection at the day of the experiment this 
was probably due to withdrawal of excessive blood volume that was not related to 
the diet. All other animals survived throughout the experiments. 





Diets in the sub-chronic toxicity test were in powder form so that the rats were “丨 
not be able to carry the diets away from the container and lose. The rats were given : 
sufficient diet everyday. The food consumption during the first 28 days, and the last i| 
25 days of the experiment for female and male rats were recorded (Table 2.6). It was | 
< M 
observed that the diet consumption of the rats from 20% sclerotial group was slightly 
higher than the control and 5% group. 
The energy content of the 20% Ptr sclerotial diet, in which cornstarch was 
substituted by Ptr sclerotium, was lower than that of the control and 5% Ptr sclerotial 
diets since it contained higher fiber content with mainly p-glucan (Cheung and Lee, 
1998). p-glucan, a glucose polymer, is highly susceptible to microbial fermentation 
and is rapidly and completely degraded in rat caecum (Gallaher, 2000). The 
microbial fermentation of p-glucan leads to the production of a number of gases and 
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short-chain fatty acids (SCFAs). SCFAs, predominantly acetate, propionate and 
butyrate, can be absorbed and thus provides a source of energy to the host 
(Benevenga et al., 1995; Gallaher, 2000). However, the energy value provided by 
P-glucan is low. The digestible energy values of cellulose, a relatively unfermentable 
fiber, and guar，a highly fermentable fiber, were 0 and 2.4 kcal/g, respectively for the 
rat (Benevenga et al., 1995). In comparison to guar, P-glucan might possess higher 
energy value as more SCFAs were produced (Gallaher, 2000). It was reported that Ptr 
sclerotium had an energy content of 3.2 kcal/g for human (Nwokolo, 1987), yet the 
energy value of Ptr sclerotium for the rat is unknown. The estimated energy content 
of the control diet (AIN-93G) and the 5% sclerotial diet should be roughly the same 
as 3766 kcal/kg diet (calculation based on standard physiological fuel value for 
I ' 
1 
protein, carbohydrate and fat of 4, 4 and 9 kcal/g, respectively) (Reeves et al., 1993). , 
The 5% sclerotial diet probably has a higher energy content than the control diet I 
because the energy content of Ptr sclerotium is higher than that of cellulose. The 20% i 
1' 
sclerotial diet probably has the lowest energy content because about 38% cornstarch ‘ 
ti 
is substituted by Ptr sclerotium. Approximately, the gross energy (GE) content of the | 
two Ptr sclerotial diets can be calculated as follow: (!• 
i w 
The GE of 5% Ptr sclerotial diet, 
=energy of control diet + energy from 50 g/kg sclerotium 
=3766 kcal/kg + (3.2 kcal/g x 50 g/kg) 
=3782 kcal/kg 
The GE of 20% Ptr sclerotial diet, 
=energy of control diet 一 energy of cornstarch substituted + energy of Ptr 
sclerotium 
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=3766 kcal/kg - (150 g/kg x 4 kcal/g) + (3.2 kcal/g x 200 g/kg) 
= 3 1 6 6 + (3.2 kcal/g X 200 g) 
=3662 kcal/kg 
The above calculations are based on the estimated energy content of the control 
diet (AIN-93G)，3766 kcal/kg (Reeves et al,, 1993). As GE of Ptr sclerotium was 
used in calculations which is greater than ME, the ME of 5% and 20% Ptr sclerotial 
diet would be in the range of 3766 - 3782，and 3166 - 3662, respectively. 
The rats will consume food to meet its energy requirement (Mayer et al, 1954； ‘ 
'丨丨 
Yoshida et al., 1958; Peterson and Baumgardt, 1971b). It was reported that the daily J 
caloric intake of rats remained constant when the diet contained from 0 to 30 percent 丨 
I ‘ 
fot (Yoshida et al., 1958). S.D. rats can adjust food intake to meet energy f 
I 
requirements within a broad range of dietary caloric content. A proportional increase 
. � f 
in consumption of diet occurs when the diet is diluted with inert materials A :i 
maximum concentration of 40% dilution of the diet could be made for weanling | 
female rats before caloric intake was reduced, whereas 50% dilution could be made I 
m 
for mature females (Peterson and Baumgardt, 1971b). The rats fed with the 20% Ptr 
sclerotial diet at the present study might consume higher amount of diet to meet their 
needs. The exact energy values of Ptr sclerotial diets available for the rats were 
difficult to determine. The total amount of diet consumption of rats from the 20% Ptr 
sclerotial diet (4213 g) was higher than that of control diet (3719 g) during the 
90-day experiment. The energy required by rats is the sum of requirements for 
maintenance, growth, physical activity, heat production, and other physiologic or 
pathologic conditions (Rogers, 1979). The maintenance energy requirement is 
usually expressed as energy required per unit of body weight in kilograms to the 0.75 
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power (BWkg0 75) (Brody, 1945; Kleiber，1975). The estimated daily main te腿ce 
energy requirement for adult rat (300g) ranged from 91 kcal to 130 kcal/EWk/乃 
(Ahrens，1967; McCraken，1975; Deb et al., 1976). Although accurate prediction of 
maintenance energy requirement of the rat requires consideration of previous 
nutritional history, physiological state，and composition of body, etc., in most cases 
the maintenance energy requirement of rat will be met by consumption of 112 
kcal/BWkgG75/day (Benevenga et al., 1995). The energy requirement for growing rat 
is almost double to that of maintenance required by adult rats. It had been reported 
that during the 4-week growth period after weaning at 21 days postpartum, the [ 
average daily energy requirement of rat is at least 227 kcal/ B WkgO75 (Peterson and : 
I i 
Baumgardt, 1971b). From the record of diet intake, the energy consumption of rats 
fed with control diet in the first 4 weeks of the experiment ranged from 208 and 223 丨 
It 
kcal/BWkg0 75/day for males and females, respectively (calculation based on the I 
energy value of AIN-93G control diet: 3766 kcal/kg), which were close to the '' 
reference value (227 kcal/ B W , , ' ' ' ) for growing rat (Peterson and Baumgardt, 、： 
1971b). In the last 25 days of this experiment, rats were considered as adults and | 
their energy consumption were from 154 and 176 kcal/BWkg''Vday for males and It 
•Ml 
females fed with control diet, respectively. The energy consumption were higher than 
the reference value (112 kcal/BW^g'^Vday) (Benevenga et al., 1995). Probably, the 
rats were continually growing at that period of time. During the experiment, the 
calculated energy consumption of rats in the 20% sclerotial group was higher than 
that of the control group (which was similar to that of 5% Ptr sclerotial) (Table 2.6). 
The actual energy consumption of rats in the 20% Ptr sclerotial group might be lower 
than calculation as the energy content of the 20% sclerotial diet was lower than 3662 
kcal/kg. Therefore, the energy consumption of rats in the 20% Ptr sclerotial group 
was considered to be normal as compared to the control group. 
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Table 2.6. The average daily food consumption of female and male rats fed with 
different sclerotial diets in the sub-chronic toxicity test. 
Experimental day 1 - 28 Experimental day 66 - 90 
5 % Ptr 2 0 % Ptr 5 % Ptr 2 0 % Ptr 
Control sclerotia 丨 sclerotia 丨 Control sclerotia 丨 sclerotial 
diet diet diet diet 
Average daily food 
consumption (g) 17.06 17.23 18.97 19.18 19.15 21.52 
Female 
Average daily 
energy intake* 也 229 247 176 179 210 
Average daily food 
consumption (g) 19.15 21.52 25.37 25.02 29.24 
Male 
Average daily 
I energy intake* 細 207 239 154 156 192 
Values are mean of group. 
*Unit in kcal/BWkgO 75/day. Calculation on energy intake based on the energy content 






2.3.3.2 Biochemical assays 
On the 45th experimental day, biochemical assays on serum of rats from the I 
sclerotial diets showed no differences to that of the control group (p < 0.05) (data not £ 
shown). All values fell within the normal reference range (Semler et al, 1992). This 
indicated that there was no adverse effect induced by 45-day feeding of Ptr 
sclerotium up to 20% of the diet. 
At termination (90^^ day), results from biochemical assays showed that there 
were no significant differences found in serum enzyme levels between the control 
and sclerotial-fed groups, except SGPT (Table 2.7). A significantly higher {p < 0.05) 
SGPT level was detected in rats fed with 20% sclerotial diet. 
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For female rats, there were no significant differences in all biochemical assays 
between all diet groups (p > 0.05) (Table 2.8). For male rats, SGPT activity of rats 
fed with 20O/O Ptr sclerotial diet was significantly higher than that of the control (p < 
0.05) (Table 2.9). Moreover，a significantly higher (p < 0.05) y-GT activity was 
observed in male rats fed with 5% Ptr sclerotial diet (Table 2.9). 
Results of AP levels of rats from the two sclerotial diet groups indicated normal 
conditions in terms of hepatobiliary and osteoblastic functions. No significant 
difference was found in the serum y-GT levels of rats fed with sclerotial diets also j 
suggested normal renal and hepatobiliary functioning as compared to the control 
group. The y-GT was less sensitive to hepatobiliary disease than AP and it is possible 
that the hepatobiliary damage must be severe before an increase of y-GT activity f 
occurs (Semler et al., 1992). SGPT and SGOT are indicators of hepatic functions, ^ 
with SGPT being more specific (Hall, 1992). SGPT levels of the male rats in 20% 
sclerotial group were elevated showing decreased hepatocytes integrity in the liver i 
and in turn the possibility of sub-optimal liver function (Table 2.9). The levels of I 
'>lj 
serum analytes, glucose, total protein, urea nitrogen and creatinine of rats (males + | | 
females) were not affected by sub-chronic feeding of 20% Ptr sclerotial diet (Table 
2.7). Normal serum glucose level indicated there were no hyper- or hypoglycemia, 
and thus normal carbohydrate metabolism of the rats (Zilva and Pannall, 1979). The 
levels of serum total protein and creatinine suggested that the rats had normal renal 
function (Ringler and Dabich, 1979). BUN level reveals both hepatic and renal 
function and does not vary with age or sex (Ringler and Dabich, 1979). BUN level of 
male rats fed with 20% Ptr sclerotial diet was lower than that of the control, although 
there was no significant difference (Table 2.9). This might indicate a sub-optimal 
function of the liver of rats in terms of the metabolism of urea nitrogen. 
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Table 2.7. Biochemical parameters in serum of rats (female + male) fed with three 
experimental diets in a 90-day sub-chronic toxicity test. 
Control (n=6) sclerotial 20% sclerotial Reference 
diet(n=7) d i e t ( n , || - g , � 
GOT (lU/p* 58.33 土 14.22 60.95 士 12.14 66.38 ±16.61 | 45.7 - 80.8 
GPT (lU/L) 33.89 ± 10.65^ 43.65 ± 15.80^^ 53.88 ±13.01^ 17.5-30.2 | 
AP (lU/L) 96.47 士 23.00 88.10 ±24.04 94.77 ± 18.04 56.8 - 128 
丫-GT (lU/L) 2.83 士 135 2.93 ± 1 0 4 2.21 ± 1.83 ^ 
BUN (mg/dL) 17.58 士 2.99 17.86 士 3.12 15.69 士 4.47 5 - 2 9 “ 
Creatinine “ 
(mg/dL) 0.6217 士 0.0780 0.6576 士 0.1353 0.5952 土 0.1039 0.20 — 0.80 { 
1 
Protein (g/dL) 6.678 士 1.201 7.405 土 1.077 6.192 士 0.6263 4 .70-8 .15 ！ 
Glucose (mg/dL) 96.90 士 17.34 85.18 士 21.56 97.04 土 22.00 5 0 - 135 f; 
丨 丨 丨 I I 1 丨：丨 
Data are means 士 standard deviation. The mean values within the same column with t 
different superscripts were significantly different at (one-way ANOVA, Tukey, p < 
0.05). ， ， ） 
*One International Unit (lU) is the amount of enzyme which can catalyze the ：1 
transformation of 1 jumol substrate per minute. S 
"Reference ranges were normal or control values of rats (Semler et al, 1992). NA, f 
data not available. | 
i w 
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Table 2.8. Biochemical parameters in serum of the female rats fed with different 
diets in the sub-chronic toxicity test. 
Control (n=4) (n=4) 20% ( n , � R e f e r e n c e J 
sclerotium sclerotium vangQ** 
GOT(IU/L) 53.88 士 11.38 59.16 土 13.53 66.11 ±13.77 || 45.7 - 80.8 
GPT (lU/L) 31.11 士 12.17 31.39 土 5.081 46.66 土 12.03 17.5 - 3 0 . 2 
AP (IU/L) 87.85 士 23.90 78.91 ±23.91 82.56 ± 17.50 56.8 - 128 
丫-GT (IU/L) 3.712 士 3.931 0.707 士 0.577 2.828 土 1.826 ~ 
BUN (mg/dL) 18.38 ±2.87 18.75 士 2.22 18.50 士 4.83 5 - 2 9 
Creatinine (mg/dL) 0.6151 士 0.0999 0.6746 土 0.1519 0.6151 土 0.1356 0 2 0 - 0 80 . • 
Protein (g/dL) 6.392 士 1.440 7.925 士 0.9989 6.259 ±0.5255 4 .70-8 .15 
Glucose (mg/dL) 96.29 士 21.72 85.43 ± 13.07 85.79 士 20 51 5 0 - 135 
I I 
Data are means 土 standard deviation. The mean values within the same column with ! 
different superscripts were significantly different at (one-way ANOVA Tukey p < : 
0.05). ， ’ ； 
*One International Unit (lU) is the amount of enzyme which can catalyze the ； 
transformation of 1 j^mol substrate per minute. 
** I'l 
Reference ranges were normal or control values of rats (Semler et al, 1992). NA, > 
data not available. | 
_ 
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Table 2.9. Biochemical parameters in serum of the male rats fed with different diets 
in the sub-chronic toxicity test. 
Control (n=2) 5% ( n , 2 0 � / � ( n , 卜 f e r e n c e 
sclerotium sclerotium … " “ 
I range 
GOT (lU/L) 67.22 ± 19.64 63.33 ± 12.37 66.66 ±21.31 145.7-80.8 
GPT(IU/L) 39.44 土 5.499a 59.99 士 2.940ab 61.11 ±10.54^ 17.5 — 30.2 
AP (lU/L) 113.7 ±6.186 100.4 士 21.97 107.0 士 7.443 56 8 — 128 
— 
r-GT (lU/L) 1.061 土 0 . 4 9 9 9 a b 5.892 士 1.591 士 1.859a NA 
BUN (mg/dL) 16.00 士 3.54 16.67 士 4.25 12.88 士 1.49 5 — 29 
Creatinine (mg/dL) 0.6349 土 0.0000 0.6350 士 0.1375 0.5754 士 0.0760 0 .20-0 .80 
Protein (g/dL) 7.250 士 0.1174 6.711 土 0.8476 6.125 土 0.7920 4.70 - 8.15 
Glucose (mg/dL) 98.14 土 9.091 84.86 士 33.73 108.3 士 19.28 50 — 135 
丨  I I I 丨| 
Data are means 士 standard deviation analyzed by One-way ANOVA. The mean : 
values within the same column with different superscripts were significantly 
different at (p < 0.05, Tukey test). [ 
*One International Unit (lU) is the amount of enzyme which can catalyze the : 
transformation of 1 ^imol substrate per minute. J 
^Reference ranges were normal or control values of rats (Semler et al., 1992). NA, � 
data not available. | 
w 
2.3.3.3 Organ per body weight 
A significantly decrease in liver per body weight, and an increase in the content 
of caecum were found in rats from the 20% sclerotial group when compared to the 
control group {p < 0.05) (Figure 2.8). 90 days feeding of 20% Ptr sclerotial diet had 
decreased rats liver per body weight by 18% as compared to that with the control diet. 
In addition, rats fed with 20% Ptr sclerotial diet showed 34.7% higher caecum weight 
than that with the control diet (Figure 2.12). Consistent statistical differences of liver 
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to body weight ratios could be found in both sex groups (Figure 2.13 and 2.14). No 
abnormal changes were observed in other organ weights with respect to body weight 
of rats from the sclerotial groups as compared to the control {p > 0.05) (Figure 2.12). 
A. Histopathology 
Histopathological examination of the liver in the control and 5% sclerotial diet 
group showed no differences. For the 20% sclerotial group, female rats showed 
normal hepatic structures under light microscopic examination, but necrotic area in 
which some hepatocytes ruptured was found in the male rats (Figure 2.15). Necrosis | 
is an evidence of cell death. Possible reasons for necrosis include binding of reactive | 
metabolites to proteins and unsaturated lipids (including lipid peroxidation and 
subsequent membrane destruction), disturbance of cellular Ca^^ homeostasis, ) 
1. 
interference with metabolic pathways, shifts in Na+ and K+ balance, and inhibition of i 
I 
protein synthesis. Since liver is capable to regenerate, necrotic lesions are not : 
I 




Liver per body weight ratios of both female and male rats from the 20% 
sclerotial group were significantly lower than that of the control (Figure 2.12, 2.13 
and 2.14). The percentage decrease of liver per body weight in male and female rats 
fed with 20% sclerotial diet were 27.1 and 13.0, respectively, showing that male rats 
were more susceptible to the change of liver. Adverse effect of long term 
consumption of high Ptr sclerotial diet could be concluded as evidenced by a 
significantly higher SGPT value of male rats from the 20% sclerotial group. The 
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decreased BUN level of male rats from the 20% sclerotial diet might also reflect the 
sub-optimal function of liver, although there was no significant difference. For the 
50/0 sclerotial group, only male rats showed lower liver per body weight ratio 
compared with that of the control group. As described in the introduction, organ per 
body weight ratio might be more sensitive than serum enzyme levels in detecting 
abnormal changes (Bianchi et al., 1968). This is evident in the present study by the 
fact that the mean liver per body weight of male rats from the 5% sclerotial group 
was significantly higher {p < 0.05) that that of the control group, even though the 
mean serum GPT levels of both groups were the similar. Adverse changes in hepatic | 
structure were not found in rats from the 5% sclerotial group, suggesting that liver ！ 
per body weight ratio was also more sensitive than morphological changes. In other j 
I 
studies, liver per body weight was found to have significantly changed in deer velvet |： 
L 
i i 
(a traditional drug) and a-methyl-(a-morpholinoethyl)-1 -naphthyl acetic acid i 
hydrochloride (a drug) treated rats before any abnormalities found biochemically or 
histologically (Bianchi et al., 1968; Zhang et al., 2000). Although the present results : 
of the biochemical and histological studies were normal as compared to the control | 
group, the liver of rats were considered adversely because of a significantly reduction f 
M N 
in its weight. On the other hand, SGPT level was increased in good correlation with 
the severity of hepatic necrosis as determined histologically in the present study 
which has been reported in other literatures (Wong, 2000; Lu, 2002; Api et al., 2004). 
This was evidenced by the hepatic histopathological examination on the female and 
male rats from different diet groups (Figure 2.15). Only distinctive peripheral 
necrosis of hepatic cells were found in male rats from the 20% sclerotial diet group 
which was consistent with the serum GPT levels detected. As compared to the 
toxin-induced hepatotoxicity, the injury evaluated in rats from the 20% sclerotial 
group was mild. A single dose of 1.25ml/kg body wt. of CCI4 was able to elevate 
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SGPT level in male rat to about 1250 lU/L and caused extensive centrilobular 
necrosis around the central vein in the liver, while the SGPT level was only around 
10 lU/L (Wong et al., 2003). The decrease in liver per body weight in male rats of the 
20% sclerotial group might be due to necrosis of hepatocytes that could not be 
compensated by regeneration. Detailed information of the reason of hepatic necroses 
requires further study by electron microscopy which is able to reveal structures of 
organelles, such as endoplasmic reticulum and mitochondria. As no histopathological 
change was found in the liver of male rats from the 5% sclerotial diet, it could only 
I 
be deduced that Ptr sclerotium had adversely affected the liver of male rats when fed 
in 20% in diet for 90 days. J 
！ 
；丨 
The abnormal change in liver might be another reason for the limited growth 
rate detected in the male rats of 20% sclerotial, since the liver is metabolically the \ 
\ 
most important organ in the body (Lu, 2002). The liver mainly performs 3 main ‘ 
丨、 J 
functions in the body including storage, metabolism and biosynthesis. Glucose ： 
absorbed from the gastrointestinal tract is transported to the liver in which it is | 
converted to glycogen and stored. Fat, fat-soluble vitamins and other nutrients are J 
« M I 
also stored in the liver. Lipoproteins are produced by the conjugation of proteins and 
the lipids synthesized in the liver. A number of functional proteins, such as enzymes 
and blood-coagulating factors are also synthesized in the liver. In addition, the liver 
which contains numerous xenobiotic metabolizing enzymes, is the main site of 
xenobiotic metabolism (Hodgson and Levi, 2004). As a matter of fact, the normal 
health or growth of rat would be influenced if the liver shows adverse change. Since 
the liver per body weight of rats from the acute Ptr sclerotium toxicity tests showed 
no differences to that of the control group, it could be deduced that the adverse effect 
of Ptr sclerotium to the liver requires a long period of time to be developed. 
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C. Caecum 
In the present study, the weight of whole caecum rats fed with the 20% Ptr 
sclerotial diet was significantly higher than that fed with the control and 5% Ptr 
sclerotial diet {p < 0.05) (Figure 2.12). This indicated that the higher fiber content in 
the 20% sclerotial diet stimulated the enlargement of caecum in the 90-day feeding 
period. It had been reported that increase in the weight of the caecum and colon were 
observed when other fibers, such as cellulose and guar pectin, were included in rat 
diets (Konishi et al., 1984). The inclusion of cellulose (insoluble fiber) in the diet led 
to greater enlargement of the colon, while glucomannan (soluble fiber) led to greater 
enlargement of the caecum (Konishi et al., 1984). In particular, the caecum wall of 
rat fed with 20% Ptr sclerotial diet in the present study were 20.2% higher than that 
of rat fed with the control diet, although the difference was not significant (Figure 
2.12). The high Ptr sclerotial diet did not only increase the content of caecum but 
also the hypertrophy of the caecum wall. Evidences were found in other studies, 
where high fiber diet containing 15% guar gum or gum arabic also elicited a marked 
enlargement of the caecum and a trophic effect on the caecal wall (Tulung et al., ‘ 
1987). It has been suggested that the microbial fermentation plays an important role 
in stimulating caecum hypertrophy (Remesy and Demigne, 1989). Also, the viscosity 
of fiber sources also may be an important factor influencing cecal hypertrophy 
(Ikegami et al, 1990). Cecal enlargement is commonly observed in rats fed high 
levels of fermentable carbohydrates that are either poorly digestible or slowly 
absorbed (Newbeme et cd., 1988). Ptr sclerotium is considered as a fermentable fiber 
as it promots the enlargement of caecum in a dose-dependent manner. Since these 
substances are incompletely absorbed in the small intestines, they reach the large 
intestine where they are fermented by microflora. It is believed that fermentation 
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products, including SCFAs, increase the osmotic load and attract water leading to 
distension and increase weight of both the large intestine itself and its contents. This 
phenomenon has no toxicological concern (WHO, 1987) but may also be considered 
as beneficial as the present results suggest that Ptr sclerotium promotes the 
enlargement of the caecum. 
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2-3.3.4 Body weight increase 
All the rats had gained body weight during the 90-day period of the experiment 
(Figure 2.16). A conspicuous difference in the body weight between male and female 
rats was observed in all diet groups. In table 2.10, it can be seen that the body weight 
gain of the male rats was nearly double that of the females. The growth curves (mean 
body weight against experimental date) of males，females and both sexes of the 
control diet group are illustrated in figure 2.17. When the data from both sexes were 
I 
pooled together, the standard deviations of the whole group were so high that the I 
effect of sclerotial diet on the parameters might be underestimated (Figure 2.17). The 
mean body weight of the male rats was 1.73 to 1.79 times higher than that of the ； 
female rats within each diet groups on the day of termination (Table 2.10). When ： 
statistical analysis was applied separately for female and male rats, the standard ； 
deviations were only about 10% of the means and significant difference was found in 
/ I 
the body weight increase of male rats between different diet groups (Table 2.10). 
These deviations came from the intrinsic difference in the growth of rats with | 
opposite sex. It has been reported that male rats gain weight more quickly and l 
become larger than females (Benevenga, et al., 1995). Therefore, the results of 
female and male rats were discussed separately whenever there was difference in the 
result of the statistical analysis. 
During the first 28 days of the experiment, maximum growth rates (body weight 
increase per day) were recorded for both female and male rats in all diet groups 
(Figure 2.16), which were ranged from 3.10 - 3.32 and 4.85 - 6.25 g/day, 
respectively. After the first 28 days of the experiment, the growth rates of rats 
declined. During the last 25 days of the experiment, the growth rates of female and 
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male rats from different diets ranged from 0.36 - 0.70 and 1.66 - 2.77 g/day, 
respectively. It was noticed that the growth rates of rats (both sexes) in the 20% Ptr 
sclerotial were the lowest among different diets (compared with the same sex) at any 
experimental period. At termination, male rats from the 20% sclerotial diet group had 
body weight increase significantly lower than that of the control and 5% sclerotial 
diet groups (p < 0.05). The body weight increase of female rats from 20% sclerotial 
was 18.09% lower than that of female rats from the control group, although there 
was no difference found (p > 0.05) (Table 2.10). 
The weight of stool collected from the last 2 days of the experimental from the 
20o/o sclerotial group was higher than that from the control and 5% sclerotial group 
i 
for almost 4 times (Table 2.10). Stool from rats in 20% sclerotial group was khaki ： 
(dull yellowish-brown) in colour while that in the control and 5% group was brown. 
It is known that feeding rats with fiber increases their fecal bulk and decreases the 
、 
gastrointestinal transit time; and the decrease in transit time are more pronounced ； 
with insoluble fibers (Fleming and Lee, 1983). From the mass of stool collected from | 
each diet group, it could be seen that the 20% sclerotial diet stimulated the rate of f 
• I 
defecation. The laxative effect was related to the fecal bulking produced by the high 
fiber content in the 20% Ptr sclerotial diet (Gallaher, 2000). The mass of stool 
produced in rats from the 20% sclerotial group was 4 times higher than that from the 
other groups. This also implied that the fiber content at this range (5% to 20%) in the 
diet might be proportional to the rate of defecation. The exact mechanisms by which 
non-starch polysaccharides increase stool output are unknown (Edwards and 
Eastwood, 1995). There are several factors affecting the fecal bulking effect of 
dietary fiber. Cellulose, which is incompletely degraded by the microbes, contributes 
to the fecal bulk by the indigestible fiber residue in the caecum. In the case of 
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fermentable p-glucans, the fiber produces an increase in microbial population that 
can significantly increase the fecal mass (Stephen and Cummings, 1980; Gallaher, 
2000). In comparison with the colour of the stool of rat from the control group (dark 
brown)，that collected from the 20% sclerotial groups were light yellowish brown in 
color. It was speculated that undigested Ptr sclerotium fiber (light yellow) was 
excreted along with stool. These results suggest that the digestion of Ptr sclerotium in 
the 20% sclerotial diets might not be complete. There was no significant difference in 
the stool weight between the rats from the control and 5% sclerotial diets (Table 
2.10), which suggested that the effect on fecal bulking of 5% cellulose and 5% Ptr 




Growth of male rats in the 20% sclerotial group was lower than the control and ： 
5% sclerotial group (p < 0.05) (Table 2.10). The dietary fiber content of the control ： 
and the 5% sclerotial group were the same (which was 5% of the diet by weight) 
/' 
while that of the 20% sclerotial group were 20% of the diet. It has been known that :i 
1 
the fiber content in diet could be digested by the microbes in the caecum into energy | 
source for the rat, but the value is low (around 2.4 kcal/g) (Benevenga et al., 1995). 
The size of caecum might increase as the high fiber content diet stimulated the 
growth of microbial population (Benevenga et al, 1995; Gallaher, 2000). As about 
38o/o of the carbohydrate source (com starch) was substituted by the sclerotial fiber, 
the metabolism and growth of the rats depended on increased diet intake. The energy 
gained from the digestion of the fiber in the 20% sclerotial diet by the microbial 
population in the caecum might be small due to difficult digestion of the sclerotium. 
Similar evidence was found in other experiments on 56-day and 28-day feeding of 
8o/o guar diet to rat, which resulted in reduced body weight gain (Cannon et al., 1980; 
Track et al., 1982). As the growths of female rats were not as rigorous as the male 
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rats (Figure 2.16), the impact of the high Ptr sclerotial diet on their growth was 
relatively lower. Although no significant difference was detected, there was 18.1% 
reduction of body weight increase in the female rats from the 20% Ptr sclerotial diet 
group as compared to the control group. In conclusion, the growth of rats from the 
20O/O sclerotial diet group was reduced with the male rats having a more obvious 
reduction. The possible reasons might be that 1) the increased diet intake could not 
compensate for the lower caloric value in the 20% Ptr sclerotial diet; and/or 2) the 
sub-chronic consumption of 20% Ptr sclerotial diet imposed some adverse effect to 
the liver which in turn led to the suppression in body weight gain. 
Table 2.10. Body weight increase and faecal output (male+female) for the three i 
experimental groups in the sub-chronic toxicity test ‘ 
I  I I I I , 
Control (n=6) sclerotial diet 20% sclerotial diet 
(n=7) (n=8) 
Body weight increase (%) 295.3 士 128.5 309.4 士 131.5 277 0 士 109 0 ‘ 
- . • ) 
Female body weight “ ： 
increase (o/o) 214.5 土 35.70 205.6 ±23.17 175.7 士 10.69 ； 
Male body weight increase f 
(o/o) 456.9 士 19.33a 447.8 土 28.06a 378.2 土 15.38& ！ 
m 
Faecal output (g)* 6.25 士 0.57 ^ 6.00 土 0.87a 23.87 士 
= = = = = = = = = = = = = = s = s = = I 
Data are means ± standard deviation. The mean values within the same column with 
different superscripts were significantly different at (one-way ANOVA, Tukey p < 
0.05). , , 
*Faecal weights were recorded as the faeces collected in the last 2 days of the 
experiment. 
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Although NOAEL can be extrapolated from acute lest, such extrapolation is 
difficult, particularly in the case of compounds that accumulate in the body (Cunny 
and Hodgson, 2004). In the sub-chronic toxicity test, 5% Ptr sclerotial diet showed 
no adverse changes in terms of body weight increase, biochemical assays, and 
histopathological studies. Although there was significantly lower liver per body 
weight ratio in male rats fed the 5% sclerotial diet, no histopathological evidence was 
1 
found. NOAEL of Ptr sclerotium could not be determined in this experiment. 
Therefore NOAEL was deduced from the results. It can be concluded that the 
I I 
( 
NOAEL of Ptr sclerotium in the 90-day subchronic toxicity test would be 6.44 g/kg 







I M I 
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2.4 Summary 
The acute toxicity tests using rats fed on Ptr sclerotium revealed no adverse ‘ 
influence in terms of body weight, biochemical assays and histopathological studies. 
From the results, it can be deduced that the NOAEL for the acute exposure of Ptr 
sclerotium was 80.27g/kg body wt. or greater. 
The subchronic toxicity tests showed that the 90-day feeding of 20% Ptr 
I I 
sclerotial diet had adverse effects on the body weight gain and liver of rats. The i 
I 
effects on male rats were more conspicuous than on the females. There was \ 
. . 1 
significant decrease in liver per body weight of female and male rats fed with 20% ] 
I 
Ptr sclerotial diet, as well as male rats fed with 5% Ptr sclerotial diet. An increase in i； 
丨  
whole caecum of rats fed with 20% Ptr sclerotial diet was observed, which is a ‘ 
( 
I I 
common physiological response to high amount of poorly digestible but fermentable � 
carbohydrates, which was of no toxicological concern. Although the lowest 
percentage of Ptr sclerotial diet (5%) tested in the subchronic toxicity test showed J 
lower liver per body weight ratio in male rats, adverse effect to the liver was not 
obvious because of the normal histopathological study and serum transaminase 
activities found. The NOAEL of Ptr sclerotium found in the subchronic toxicity test 
was 6.44 g/kg body wt./day. 
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Chapter 3 Hepatoprotection of Ptr sclerotium 
3.1 Introduction 
3.1.1 Hepatotoxicity 
Liver is metabolically the most important and complex organ in the body. It is 
responsible for the metabolism of nutrients as well as drugs and toxicants. Liver is 
often the target organ since it has a high concentration of xenobiotic-metabolizing 
I 
enzymes (mainly cytochrome P-450), which reduce the toxicity of most toxicants 
and make them more water-soluble so that they can be excreted. Hepatocytes \ 
I 
(hepatic parenchymal cells) comprise the bulk of the organ. They play a central role '] 
in metabolism as they contain high concentration of the enzymes (Hodgson and Levi j； 
， 丨  
2004). Some toxicants are activated to be lesion-inducing and hepatic lesions are : 
/ I 
often centrilobular as there is high concentration of cytochrome P-450. Another ；、 
reason is that there is also lower glutathione concentration compared to that in other 
X I 
parts of the liver (Smith et al., 1979). Chemically induced cell injury involves a : 
u 
series of events occurring in the affected animal and often in the target organ itself: 1) 1 
m 
the chemical agent is activated to form the initiating toxic agent, 2) the initiating 
toxic agent is either detoxified or causes molecular changes in the cell, 3) the cell 
recovers or there are irreversible changes, 4) irreversible changes may culminate in 
cell death (Hodgson and Levi, 2004). The initiation of cell injury has several 
mechanisms, such as inhibition of enzymes, depletion of cofactors or metabolites, 
depletion of energy (ATP) stores, interaction with receptors, and alteration of cell 
membranes (Hodgson and Levi, 2004). Many toxicants can induce several types of 
injuries to the liver where aflatoxins and CCI4 can induce steatosis, necrosis and 
cirrhosis (detailed mechanisms refer to 3.1.3 and 3.1.4). 
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3.1.2 Potential hepatoprotection effect of Ptr sclerotium 
A number of mushroom preparations, such as lentinan, schizophyllan and PSK 
have shown clinically significant efficacy against human cancers and are used as 
biological response modifiers (BRM) (Mizuno, 1999). These 3 preparations are 
approved in Japan as prescription drugs for the treatment of cancer (Mizuno, 1999). 
All of these preparations are chemically p-o-glucans in nature or p-D-glucans linked 
to proteins. The biological activity of p-o-glucans is influenced by their solubility in 
water (Ishibashi et al, 2001), molecular weight (Okazaki et al., 1995; Cleary et al., 
1999; Mueller et al, 2000), branching rate (Cleary et al, 1999; Kataoka et al., 2002), ： 
triple helical solution conformation (Muller et al, 2000; Falch et al., 2000), and ； 
p-(l->6)-bonding system in the p-(l->3) major chain (Cleary et aL, 1999). ； 
Numerous reports have documented the ability of p-glucans to nonspecifically ‘ 
I 
activate cellular and humoral components of the host immune system in human ;� 
(Tzianabos, 2000). Thus it would be interesting to investigate if Ptr sclerotium has 




It has been shown that the polysaccharide in Ptr sclerotium has preventive 
hepatoprotection against acute liver injury induced by CCI4 in mouse (Huang and Hu, 
2000). Ptr sclerotial polysaccharide was fed to the mice (species not specified) for 10 
days before the administration of the hepatotoxin CCI4. CCI4 was applied at 0.1% in 
peanut oil at lOml/kg b. wt. i.p. 1 h after the administration of Ptr polysaccharide on 
the 10th day Following a 24 h fasting, glutamate pyruvate transaminase (GPT) was 
evaluated in serum of each mouse. For the control and CCI4 control group, distilled 
water was fed instead of Ptr polysaccharide to the mice for 10 d and CCI4 was 
applied to CCI4 control group only. The mice fed with Ptr polysaccharide showed a 
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significantly lower level of serum GPT than that of the CCI4 control group (p < 0.01). 
Further study on the potential protective effect of Ptr sclerotium was 
investigated in vivo with two toxins in this research. The first one is CCI4，which is 
an extensively studied hepatotoxin (Recknagel et al., 1989; Castro et al., 1997; Boll 
“al, 2001; Taniguchi et al, 2004). Based on the above findings and the availability 
of the toxicological information of CCI4, the hepatoprotective effect of Ptr sclerotium 
was investigated in more details sense using this toxin. 
I 
The second toxin is aflatoxin B, (AFBi), which induces hepatotoxicity as well f 
1 
as genotoxicity in animal models. To induce hepatotoxic effect, CCI4 and AFBi j 
. 1 
involve different mechanisms, though they are both initiated by cytochrome P450 ： 
enzymes (Rose and Levi, 2004). The formation of DNA adducts by the metabolites ‘ 
I I 
of AFBi is the cause for both hepatotoxicity and genotoxicity of liver cells since they � 
are the sites of AFBi biotransformation. It is interesting to investigate if Ptr 
sclerotium can protect liver from AFBi injury on hepatocellular and genetical levels. i 
Chlorophyllin (CHL), a known antioxidant, antimutagen and anticarcinogen, had ^ 
been shown to form molecular complexes with AFBi (Dashwood et al., 1997, Egner 
et al., 2001). It was used as a positive control for the comparison of potential 
hepatoprotective effect of Ptr sclerotium against AFBi in the experiment. 
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3.1.3 Toxicity of CCI4 
Tetrachloromethane (CCI4) is a colourless organic liquid at room temperature. 
By the 1930s, it was widely used as a constituent of fire extinguishers and a dry 
cleaning agent. However, as its fatal toxicity resulting from thermal decomposition 
was known, it was banned in fire extinguishers. Other uses have included: in making 
nylon, as a solvent for rubber cement, soaps, insecticides, etc. CCI4 was also used as 
an insecticidal grain fumigant which is now outlawed by the USEPA (EPA, 1984). It 
1 
was also used in making chlorofluorocarbon propellants and refrigerants. However, 
since the establishment of the Montreal Protocol on Subtances that Deplete Ozone i 
I 
the Layer (1987) and its amendments (1990 and 1992), the production and j 
consumption of carbon tetrachloride has dropped according to a phase-out timetable 
drawn. ‘ 、 
彳丨 
The acute toxicity of CCI4 has been studied extensively during the past 40 years. 
Acute (short-term) inhalation and oral exposures to carbon tetrachloride have been i 
jf 
observed primarily to damage the liver and kidneys of humans. Depression of the ' 
central nervous system has also been reported (WHO, 1999). Symptoms of acute 
exposure in humans include headache, weakness, lethargy, nausea, and vomiting 
(WHO, 1999). Acute animal exposure tests, such as the LC50 (lethal concentration, 
normalized to the concentration in environment in which the organisms were 
exposed) and LD50 (lethal dose, normalized to the weight of the animal) tests in rats, 
mice，rabbits, and guinea pigs, have demonstrated CCI4 to have low toxicity from 
inhalation exposure, low-to-moderate toxicity from ingestion, and moderate toxicity 
from dermal exposure (US Dept. of Health and Human Service, 1993). 
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c c u is distributed throughout the body, with its highest concentrations being 
found in liver, brain, kidney, muscle, fat and blood. The severity of toxic effects of 
CCI4 on the liver depends on a number of factors such as species, route and mode of 
exposure, diet or the co-exposure to other compounds (Lu and Kacew, 2002). For 
instance, the CCI4 susceptibility of male S.D. rats has been proven to be higher than 
that of females (WHO, 1999). The LD50 of male S.D. rats was 3029 mg/kg (Klaassen 
and Plaa, 1969) while that of female was 6603 mg/kg (Lundberg et al, 1986) when 
CCI4 was administered intraperitoneally. When administered in the same route, male 
Swiss Webster mice had a higher LD50 (4144 mg/kg) than male S.D. rats indicating j 
the species difference (Klaassen and Plaa, 1967). Administration of 1.25ml/kg body S 
t 
wt. CCI4 led to severe centrilobular type of necrosis and fatty degeneration of the j 
liver to rats and induced very high SGPT (1859 lU/L) and SGOT (2452 lU/L) ： 
11 
activities, respectively in rat (Wong et al., 2000). ‘ 
丨1 
{ 
Metabolism of CCI4 is initiated by cytochrome P450 as follows: 1) An electron 
is transferred to the C-Cl bond, forming an anion radical that eliminates chloride, and 3 
At 
then the reactive trichloromethyl radical is formed. The radical may undergo both 3 
oxidation and reduction. The possible pathways of the biotransformation of 
trichloromethyl radical are shown in figure 3.1. The reactive radical metabolic 
intermediate of CCI4 may covalently bind to macromolecules, produce lipid 
peroxidation, and result in the loss of intrahepatic calcium homoeostasis (Shertzer et 
al, 1988). 2) An 
important elimination pathway of trichloromethyl radicals is the 
reaction with molecular oxygen, which results in the formation of 
trichloromethylperoxyl radicals (CCI3OO') (Packer et al., 1978; Shah et al., 1979; 
Mico and Pohl, 1983; Pohl et al., 1984; McCay et al., 1984). 3) CCI3OO. is more 
reactive than the trichloromethyl radical (Dianzani, 1984) and may react with lipids, 86 
leading to lipid peroxidation. 4) CChOO' is supposed to further react to produce 
phosgene, which may interact with tissue macromolecules or with water, 5) 
producing the end products of hydrochloric acid and carbon dioxide (Pohl et al., 
1984). Alternatively, under anaerobic condition, CbC- abstracts a hydrogen atom 
from polyunsaturated lipids leading to the production of a lipid radical and a stable 
molecule of chloroform (CHCI3). The lipid radical may react with other cellular 
constituents by oxygen addition and may cause a cascade of disturbance with the cell, 
such as peroxidation of lipids in endoplasmic reticulum (Packer et al., 1978; 




CCI4, has been studied biochemically and pathologically more extensively than f 
I 
any other hepatotoxicant. It has been widely used to induce experimental liver injury ；| 
in animal models and is a classical example of a chemical activated by cytochrome j 
J 
P450 to form a highly reactive free radical (Recknagel et al., 1989; Wong et al, 2000; � 
\ Boll et al., 2001; Ulicna et al, 2003). In particular, the necrosis induced by CCI4 is “ 
most severe in the centrilobular liver cells that contain the highest concentration of 1 
j f 
the P450 isozyme responsible for CCI4 activation (Hodgson and Levi, 2004). I 
I I 
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Fig. 3.1 Biotransformation of carbon tetrachloride (Adapted from Harris & Anders， 
1981; Anders & Jakobson, 1985; McGregor & Lang, 1996). 
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3.1.4 Toxicity of AFBi 
The aflatoxins are produced by the filamentous fungus Aspergillus flavus and 
related aspergilli. These fungi affect a number of seeds and grains including peanuts, 
com，cottonseed, a number of tree nuts. Aflatoxins are therefore relatively easy to 
manufacture, simply by practicing poor grain husbandry. A great deal is now known 
about the enzymology and molecular biology of aflatoxin biosynthesis and it is a 
very complex process (Lu and Kacew, 2002). AFBrinduced hepatotoxicity and 
I I 
carcinogenicity are known to vary among species of livestock and laboratory animals, | 
which may depend on the particular enzyme profile of the organism. i 
! 
The acute structural and functional damage to the liver, as well as the principal | 
target organ for aflatoxins has been reproduced experimentally in laboratory animals ！ 
(Liu et al, 2001; Doi et al, 2002; Towner et al, 2002). Biotransformation plays an V 
important role in the bioactivity and disposition of aflatoxins as bioactivation of ^ 
aflatoxins Bi is necessary for its toxic and carcinogenic effects. Figure 3.2 shows the ]i 
I t 
biotransformation pathways for AFBi. The epoxidation of the terminal furan ring i 
I I 
double bond of AFB丨 by cytochrome P450 generates the very potent electrophilic 
AFBi-8,9-epoxide which can bind to DNA, RNA and proteins. With the formation of 
DNA adducts，the risk of cancer is increased and acute toxicity may also be 
associated because of the occurrence of adduct formation in the sites of active gene 
transcription, such as at ribosomal genes. Active genes are not associated with 
histone proteins and thus are more accessible to the epoxide. Reduced nuclear or 
ribosomal RNA synthesis is attributed to inhibit or alter chromatin template function 
(Yu, 1981). Like that of DNA, guanine nucleotides of RNA can also form adducts 
with AFB,-epoxide (Lin et al.’ 1977). These RNA adducts, especially the messenger 
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RNA，are believed to interfere with cellular protein synthesis and to inhibit protein 
translation at ribosomes in acute aflatoxicosis (Sarasin and Moule, 1975). The 
AFB,-epoxide can also bind covalently to proteins, which affects structural and 
enzymatic protein functions. The acute aflatoxins toxicity may be related to the 
binding of AFB i-epoxide with the structural and enzymatic proteins because of their 
abundance and critical role in cellular homeostasis (Ueno et al., 1980). Virtually all 
the toxic effects of AFB� are recognized to be attributable to the action of its 
metabolites, which are capable of reacting with cellular macromolecules. The 
conjugation of the reactive epoxides with glutathione is an important detoxification } 




A single high dose (lOmg/kg) of AFB, by gavage, liver failure of the rat led to | 
the death of the animal (Liu et al, 1988). While with a lower dose (0.25mg/kg) of | 
J 
AFBi，biochemical and histological evidence of cell death is found. Though AFBi is | 、 
mutagenic, a single dose can rarely induce cancer in mammals. Mutagenesis induced , 
by P450 IA2-activated AFBi consisted mainly of GC to TA mutations (�65o/o) | 
which was studied in human cell culture (Trottier et al., 1992). Aflatoxin Bl , | 
aflatoxin Ml , 
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Fig. 3.2 An overview of biotransformation pathways of AFBi (Bammler et al., 
2000). 
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and aflatoxin G1 have been shown to cause various types of cancer in different 
animal species (Hsieh et al., 1984). Among the congeners，AFB, is the most potent 
for carcinogenicity (Hsieh et al., 1984). The International Agency for Research on 
Cancer (lARC) considers the data for human liver cancer after aflatoxin exposure to 
be sufficient to warrant its classification as a human carcinogen in 1987 (lARC, 
1987). 
3.1.5 Bioactivity of chlorophyllin 
i 
Chlorophyllin (CHL) is obtained by hydrolyzing the chlorophyll to remove its j 
N 
phytyl alcohol. CHL was known to have in vitro and in vivo protective properties | 
against the mutagenic activities of various classes of carcinogens such as aflatoxin Bj, | 
heterocyclic amines, polyaromatic hydrocarbons and nitrosamines (Dashwood et al, | 
1991; Sarkar et al., 1994). More recently, the anticarcinogenic activity of CHL has ( 
been studied in several species (Abd-Allah et al, 1999; Park et al., 2000; Liu et al., [ 
2001). Collectively, the results from these studies support the chemopreventive role 
for CHL against aromatic carcinogens in various target organs of rats, mice, and f 
rainbow trout. In vivo mechanistic studies have indicated that inhibition is most 
effective when CHL is administered simultaneously with the carcinogen, which 
allows the direct interaction (molecular complex formation) between CHL and the 
carcinogen (Dashwood, 1997). The findings were consistent with the “interceptor 
molecule" hypothesis (Hartman and Shankel, 1990), which proposes that 
chlorophyllin form molecular complexes with aromatic carcinogens, reducing their 
uptake from the gut and subsequent systemic bioavailability in the tissues. Thereby, 
in the present project, CHL was used as a positive control for the comparison to the 
potential protective effect of Ptr sclerotium. 
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Apart from antimutagenic and anticarcinogenic properties, CHL also protects 
liver from oxidative damages produced by gamma rays (y-rays), photosensitization, 
and some endogenous systems like ascobate-Fe^^ and NADPH-ADP-Fe^^ induced 
system (Kamat et aL, 2000). After oxidative stress induced by ROS, products of 
peroxidation formed were measured as thiobarbituric acid reactive substances 
(TEARS) (Kamat et al, 1997) and protein carbonyls were measured as an index of 
protein oxidation (Palamanda and Kehrer, 1992). CHL treatment (50 ^iM) 
significantly inhibited in y-rays- (53%), photosensitization- (76.1%), ascobate-Fe�.-
I 
(34.60/0) and NADPH-ADP-Fe'^- (47%) induced TEARS formation in rat liver ‘丨 
I 
mitochondria in vitro (Kamat et al, 2000). CHL also decreased protein oxidation in a ！ 
i 
dose-dependent manner in oxidative damage induction by y-rays in rat liver j 
i 
mitochondria in vitro (Kamat et al., 2000). At 50 }iM, CHL significantly lowered | 
protein carbonyls formation by 89.4% (Kamat et al, 2000). Moreover, single cell f 
I 
suspension of liver of mice fed with 1% CHL in water showed significantly lower | 
TBARS value by 61.41% as compared to the control after photosensitization (Kamat J, 
et a l , 2000). These showed that CHL acts as an antioxidant in the rats' liver I： 
mitochondria against oxidative damage to lipid as well as to protein induced by the 
above mentioned radiations and endogenous systems. 
3.1.6 Comet assay 
Biochemical assays and histopathological were used to detect general adverse 
changes in target organs caused by AFBi, while those changes occurring in the 
molecular level require other specific methods. For measuring liver genoprotection 
or genotoxicity, several analyses can be employed which include: enzyme assays and 
western blot immunoassays for measuring the activity and expression levels of 
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bioactivation or detoxification enzymes induced or depressed by xenobiotics; 
micronucleus assay for detecting chromosomal aberrations in diving cells; Ames test 
for detecting mutagenic substances; comet assay for detecting DNA breakages; and 
High Performance Liquid Chromotography for measuring DNA adduct (Manson et 
“/., 1997; Breinholt et al, 1999; Miyata et al., 2004). Among these techniques, comet 
assay is a relatively simple, fast, and sensitive one in evaluating possible genotoxic 
damage from, or genoprotective effect of a substance (Tice et al., 2000; Collins, 
2004). The advantages and working principle of comet assay are discussed below. 
« i 
Comet assay, which is also called single cell gel electrophoresis assay, is a I 
. � 
simple, rapid and sensitive technique for detecting and analyzing DNA damage in ^ 
. . i 
individual cells. This technique of detecting and quantifying DNA damage in \ 
individual cells was developed in 1984 by Ostling and Johanson. This method 
i i, 
involved a microgel electrophoresis, in which the cells were embedded in an agarose ； 
gel placed on a microscope slide and the cells were lysed by detergents and high salt. � 
The liberated DNA fragments were electrophoresed under neutral conditions. i 
However, this technique could only detect double-strand DNA breakages with 
limited application to studies involving radiation or radiomimetic chemicals only. 
Later，a microgel technique involving electrophoresis under alkaline conditions (pH 
� 1 3 ) was developed and was only published first as Comet assay by Singh and his 
colleagues in 1988. This method is capable of detecting single-strand breaks and 
alkali-labile lesions in the DNA of individual cells (Singh et al., 1988). With the 
same underlying principles, different microgel methodologies have been developed 
based either on the neutral assay of Ostling and Johanson (1984) or the alkaline assay 
of Singh et al (1988). In general, the cells are mixed with molten low-melting 
agarose (approximately 37°C), and the mixture was then placed on a fully frosted 
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microscope slide where it is allowed to harden. The cells were lysed to remove 
cellular proteins using detergent and high concentration of salt, and the liberated 
DNA was electrophoresed for a short time under alkaline or neutral conditions. 
Staining of DNA was followed with DNA-specific fluorescent dye, and then DNA 
damage was evaluated by fluorescence microscopy. Cells with increased DNA 
damage display increased migration away from the nucleus and towards the anode. 
Figure 3.3 illustrates typical fluorescent microscopy of cells with normal or damaged 
DNA in comet assay. 
While Comet assay is measuring the amount and sizes of DNA fragments within 
；l| 
a cell, it is necessary to convert DNA damages induced in the nucleus into DNA ；' 
fragments before being detectable. Prior to electrophoresis, samples on the slides are | 
immersed in alkaline (pH > 13) buffer to produce single-stranded DNA and to ' 
I: 
express alkali labile sites (ALS) as single strand breaks (SSBs). It has been reported ； 
that the sensitivity to detect alkali-labile lesions depends on the length of the | 
unwinding time allowed for expression, while maintaining constant duration for j 
electrophoresis (Vijayalaxmi et al., 1993). Following the alkaline unwinding process, , 
both the neutral and alkaline electrophoresis can display SSBs and DSBs. For 
alkaline electrophoresis, the majority of apurinic sites，apyrimidinic and the 
alkali-labile sites can also be displayed as well. In addition, breaks can be introduced 
at the site with modified DNA base by treating the DNA with lesion-specific 
glycosylases or endonucleases such that fragments can be produced for Comet assay 
detection (Fairbaim et al, 1995; Angelis et al, 1999). 
In this part of the project, the in vivo genotoxicity of, and the potential 
hepatoprotective effect of Ptr sclerotium against aflatoxin B! were investigated by 
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Comet assay because of its several merits as compared to other genotoxicity assays 
such as the scoring of micronuclei, structural chromosomal aberrations and the 
detection of DNA repair synthesis. They include the sensitivity for detecting low 
levels of DNA damage; the ease of application; the relatively lower cost; the 
requirement for smaller amount of cells per samples and relatively less 
time-consuming for a complete experiment. During the last decade, Comet assay has 
been utilized as a basic tool in research area ranging from human and environmental 
biomonitoring to DNA repair processes to genetic toxicology (Tice, 2000). For its 
attractiveness to genetic toxicology, Comet assay is not only a potentially 
high-throughput screening assay, it can also distinguish between genotoxicity versus 丨 
cytotoxicity induced chromosomal damage, and also between genotoxic versus 丨: 
non-genotoxic carcinogens (Tice, 2000). j 
For the simplicity, reliability and consistency of the assay, the Trevigen's ； 
CometAssayTM kit was employed. TBE neutral electrophoresis following alkaline | 
unwinding was chosen for genetic toxicology of AFBi. Using TBE circumvents the 
problems which are associated with the use of non-buffered alkali electrophoresis, 
such as difficulties in controlling voltage, and the poor DNA migration due to 
saturation of charge by sodium ions. Tail DNA (%), tail length and Olive tail moment 
were used to indicate the extent of DNA damage in cells. The most commonly used 
methods in quantifying DNA migration include the folio wings: 
A. The tail length (j^m) which evaluates the extent of DNA damage and is measured 
by the distance between the head and the last detectable DNA fragment. 
B. The tail DNA is the percentage of DNA that migrated from the head, and it is 
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calculated as the fraction of tail optical intensity measured by the computer and 
fluorescent microscope system over the total comet optical intensity as shown 
below. 
Tail DNA (%) = (Tail Optlnten / (Head Optlnten + Tail Optlnten)) X 100% 
where Optlnten is optical intensity measured by the Komet^'^ 3.1 Kinetic Imaging 
software. 
H i 
C. The product of the first 2 parameters is the tail moment. Olive tail moment is 
f 
calculated in similar way to tail moment in which only the distance of center of j 
i 
gravity between head and tail is used instead of tail length. 
Tail moment = Tail DNA (%) x tail length (jiim) t 
I: 
I I 
Control P388D1 cells Damaged P388D1 cells , 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ (Ethyl methane sulphonate, 2mM, 6 h) '' 
l iP I^P圓丨 
H T H e T e 
H : Centre of gravity of the head 
T : Centre of gravity of the tail 
Tail length = distance C - E 
Tail DNA = proportion of DNA in the tall 
Olive tail moment = Tall DNA x distance H - T 
Fig. 3.3 A fluorescent micrograph showing typical image of a) a control cell with 
intact nucleus and b) a damaged cell (Duez et al, 2004). P388D1, murine leukemia 
cells. Damaged cells were treated with ethyl methane sulphonate. 
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3.1.7 Objectives 
As interests in studying the various medicinal and health protection values of 
Ptr are emerging, the potential protective functions of Ptr sclerotium to the liver, 
which is the most important organ in toxins biotransformation, was also investigated 
in latter part of this Chapter. A number of mushrooms have shown curative 
hepatoprotection effect in rats after chemical-induced liver injury (Akamatsu et al., 
2004; Barbisan et al., 2002). Hence, it will be interesting to find out the liver 
protection potential of Ptr sclerotia. The investigation of the potential 
I 
hepatoprotective effect of Ptr sclerotia involved the use of two hepatotoxins, 丨 
tetrachloromethane (CCU) and aflatoxin B, (AFB,) to induce liver injury. ； 
Intervention of Ptr sclerotia was either applied before (preventive) or after that i 
i 
f 
(curative) the administration of toxins. , 
I 
Ptr sclerotium was incorporated into the daily diet of rats used for ‘ 
I 
hepatoprotective study. Preventive and curative protective tests were carried out in ； 
which CCI4 or AFBi was administered after and before the feeding period of the 丨 
sclerotial diet, respectively. Serum GPT and GOT, and liver per body weight were 
used as the bio-indicators of acute liver injury, while the gross and microscopic 
morphology of the liver were used to examine the extent of injury and possible 
recovery. Comet assay was also employed to investigate the genotoxicity on hepatic 
cells brought by the administration of AFBj and the possible protective effect of Ptr 
sclerotium. The value of each indicator from the Ptr sclerotium feeding group was 
compared to that of the control group. Protective effects of Ptr sclerotium were 
assessed based on statistical analyses on the values of the bio-indicators between 
groups. 
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3.2 Materials and Methods 
3.2.1 Sample materials and chemicals 
Sclerotia of P. tuber-regium were pilled and milled in the same way as 2.2.1. 
Aflatoxin B, (AFBi) from A. flavus (Sigma-Aldrich, St. Louis, MO, USA; 
crystalline form) was dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. 
Louis，MO, USA) and made to a final concentration of lOmg/ml of DMSO. The | 
solution was frozen at until use. Tetrachloromethane (CCU) was purchased 
from Sigma-Aldrich Co., Ltd (MO, USA). Chlorophyllin purchased (Sigma-Aldrich, ^ 
St. Louis, MO, USA) was dissolved in distilled water at a concentration of lOmg/ml. 
It was prepared freshly before use. , 
I: 
3.2.2 Curative and preventive tests of Ptr sclerotium 
against CCVinduced hepatotoxicity I 
3.2.2.1 Animal and diets 
The AIN-93G was used as the control diet for the hepatoprotection experiment 
with 20% and 30% Ptr diets made by substituting the whole fiber content and 
appropriate amount of cornstarch from 1kg AIN-93G with Ptr sclerotium powder 
(Table 2.3). 
Male Sprague-Dawley rats, weighing 260-280g were obtained from the 
Laboratory Animals Service Centre, The Chinese University of Hong Kong. They 
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were housed in a controlled-environment of 18-20 ^C, humidity 54-56% with 
12-hour light-dark cycle and were supplied with standard rodent chows and tap 
water ad libitum. The animals were acclimatized for 5 days before the start of the 
experiments. 
3.2.2.2 Dose-response of CCI4 on rat model 
Four dosages of CCI4： 0，0.7, 1.0 or 1.8 ml/kg body wt. were used in the 
< 1 
experiments representing the control, low, medium and high dose groups (WHO, | 
！I 
1999; Fukao et al., 2004; Lee et al, 2004). CCI4 of each dose were dissolved in com ！ 
I I 
oil (Mazola, USA) as vehicle to a final volume of 5ml. For each group, 4 rats were ^ 
administered with the corresponding dosage of CCI4. After 24 hr, each rat was 
weighed and anaesthetized with diethyl ether for blood withdrawal by heart puncture. 
Termination was then carried out using carbon dioxide and liver from each rat was i 
dissected out for weight measurement and histopathological examination similar to 
2.2.2.5. I 
3.2.2.3 Biochemical assays 
Enzyme activities of serum pyruvic transaminase (SGPT) and serum glutamic 
oxaloacetic transaminase (SGOT) in the blood serum of rat were measured 
according to the procedures same as in 2.2.2.4 and the results were used to illustrate 
the extent of hepatotoxicity in the rats. 
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3.2.2.4 Curative hepatoprotection test on Ptr 
CCI4 dissolved in com oil (50% v/v) was injected intraperitoneally at a level of 
1.5 ml/kg body weight to 8 rats. The experimental animals were then caged 
individually and were divided into 2 groups, namely: the control group (4 rats) 
which was fed with the control diet AIN-93G; and the treatment diet group (4 rats) 
feeding with 30% Ptr sclerotial diet (see table 2.2) for 4 days. At the end of the 
day of experiment, the diets were taken away and the rats were fasted for 18 h 
I I 






CCU Blood collection, | 
injection termination 
Groups ^ ^ ^ 
Control 
Sclerotial diet 
I I , 
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l'.] Fasting 
Fig. 3.4 Experimental procedures of curative hepatoprotective effect of 30% Ptr 
sclerotial diet on rat against 1.5 ml/kg CCI4. 
3.2.2.5 Preventive hepatoprotection test on Ptr 
The experimental animals were caged individually and were divided into 2 
groups, namely: the control group (4 rats) which was fed with the control diet 
AIN-93G; and the treatment diet group (4 rats) feeding with 20% or 30% Ptr diet for 
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one week. At the end of the day of experiment, CCU dissolved in com oil (50% 
v/v) was injected intraperitoneally at a level of 0.7ml/kg body weight to both groups 
of rats. All the rats were sacrificed 24 h after receiving the administration of CCU. 
The experimental design is illustrated in figure 3.5. 
Another experiment was carried out with the same experimental design using 
30% sclerotial diet instead. 
Collection of 
CCI4 i.p blood and liver; J 
Q.7ml/kg Termination ； 
Groups ^ ^ i 
Control l：：：：：!：：：：：：：：^；：；：；：：；；；：；；；：：：：：；：； 3 1 ’ 
Sclerotial diet ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
> 
0 7 8 day 
^ Sclerotial diet 
口 Normal rodent chows 丨 i- -1 
“」Fast ing 
Fig. 3.5 Experimental procedures of preventive hepatoprotective effect of 20% or 
30% Ptr sclerotial diets on rat injected intraperitoneally with 0.7 ml/kg body wt. ‘ 
CCU. 
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3.2.3 Preventive tests of Ptr sclerotium against 
AFBi-induced hepato- and geno-toxicity 
The methodologies of both dose-response and preventive hepatoprotection 
experiments were the same in 3.2.2 except the design of experiments shown below. 
3.2.3.1 Dose-response of AFBi on rat model 
The experiments were carried out to investigate the dose-response effect of 
AFBi in vivo using male S.D. rats. The experiments consisted of four groups, the | 
control and the AFBi treatment group at the doses 0.7, 1.0 and 1.5 mg/kg body wt., 
respectively. For each group, 4 male S.D. rats were caged individually and allowed 
to access control diet AIN-93G (Table 2.2) and tap water ad libitum. For the 
treatment group, AFBi in DMSO (lOmg/ml) was administered i.p. at 0.7mg/kg body 
wt.. Saline at 0.9% was used to dilute the AFBi-DMSO solution to 1% by volume. 
The above steps were repeated for two other groups using l.Omg/kg or 1.5mg/kg. In 
the control group, the rats were administered with 0.15ml/kg body wt. of DMSO 
dissolved in 0.9% saline (1%, v/v). After the injection of the toxin, the rats were 
fasted for 24 h before their blood was drawn. Termination of rats was carried out 
using carbon dioxide. 
3.2.3.2 Preventive test of Ptr against AFB, 
Twelve male S.D. rats were divided into 4 groups, which were the control 
group, the negative control group, the Ptr sclerotial group and the CHL positive 
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control group. The rats in the Ptr sclerotial group were fed with 20% Ptr sclerotial 
diet and tap water for 7 days, while those in the control, negative control and CHL 
positive control groups were fed with control diet AIN-93G (Table 2.2). At the end 
of the 7th day of the experiment, AFBi was administered i.p. at 0.7mg/kg body wt. to 
rats of the negative control group, Ptr sclerotial group and CHL positive control 
group. For the control group, DMSO in saline was administered at 0.07ml/kg body 
wt.. Immediately after the administration of AFBi, the rats in the CHL positive 
control group were injected i.p. with CHL 1 Omg/kg body wt. dissolved in 0.9% 
saline solution. For the control, negative control and Ptr sclerotial groups, saline 
were administered at 1 ml/kg body wt.. Blood was collected 24h after the injection of I 
toxin or vehicle and termination was followed. The experimental design of the 
preventive protection of Ptr sclerotial diet against AFBi is illustrated in figure 3.6. 
_ Injections Termination 1 
G r o u ^ O ^ ^ I 
Control ^ ^ _ __ 
i 
Negative ^ ^ 





0 7 8 Day 
^ Sclerotial diet 
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• A F B , / l % D M S O • Chlorophyllin/dH20 ^」Fasting 
Fig. 3.6 Experimental procedures of preventive hepatoprotective effect of 30% Ptr 
sclerotial diet on rat injected AFBi intraperitoneally (0.7 mg/kg body wt.). 
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3.2.3.3 Biochemical assays 
In both experiments, the rats were anaesthetized with diethyl ether 24 h after 
the administration of AFBi or the vehicle. Serum of each rat was collected and 
analyzed for SGPT and SGOT according to the procedures described in 2.2.2 A 
3.2.3.4 Histopathological examination 
The removal of liver from the animal and preparation for histopathological I 
examination were in the same way as in 2 . 2 . 2 . 5 . ； 
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3.2.4 Comet assay 
3.2.4.1 Reagent preparations 
A. Phosphate buffered saline 
PBS solution was prepared by dissolving 8.182g sodium chloride, 0.20Ig 
potassium chloride, 0.204g potassium dihydrogen phosphate and 1.15g sodium 
hydrogen phosphate (dibasic) in 1000ml distilled water. , 
B. Alkaline solution (pH > 13) 
Sodium hydroxide pellets (0.6g) were dissolved in 49.75 ml distilled water 
containing 250 [il 200 mM EDTA. The solution was stirred until fully dissolved. The 
solution was allowed to cool to room temperature before use. 
C. Tris Borate EDTA (TBE) electrophoresis buffer 
lOX TBE solution was prepared by dissolving 108g Tris base, 55g boric acid 
and 9.3g EDTA (disodium salt) in 900ml distilled water. The volume was adjusted to 
IL and was autoclaved. The solution was stored at room temperature and was 
diluted to IX with distilled water to prepare working strength buffer. 
D. Tris EDTA (TE) buffer 
TE buffer was prepared by adding 0.2422g of Tris-HCl (Sigma-Aldrich, St. 
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Louis, MO, USA) and 1ml of 200mM EDTA (from Trevigen's Comet A s s a y ™ kit) to 
200ml distilled water. The solution (10 mM Tris CI, 1 mM EDTA, pH7.5) was 
adjusted to pH 7.5 with HCI or NaOH solution. 
E. SYBR® Green I staining solution 
SYBR® Green I concentrate (10，000X concentrate in DMSO) was provided by 
the Trevigen's CometAssay^^ kit. One microlitre of the concentrate was diluted with 
10 ml TE buffer, pH 7.5. The diluted stock is stable for several weeks when stored at 
4°C in the dark. 
3.2.4.2 Procedures 
All steps were performed at room temperature, and under dimmed light to 
prevent DNA damage from UV unless otherwise specified. 
A. Cell dissociation 
A portion of the median lobe of the rat liver from the experiment of AFBi 
induced hepatotoxicity was minced on an aluminum foil cooled with ice. The 
minced tissue was then transferred to a 50ml Falcon tube containing 20ml ice-cold 
IQo/o (v/v) DMSO in saline. The tube was recapped and stored in a -80°C freezer 
until comet assay is carried out. 
When comet assay started, the mixture was thawed in a 3TC water bath for 2-3 
min to melt the cryopreserving liquid, which was then decanted. The tissue was 
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transferred into a 50-ml flask with 10ml of collagenase (15 units/ml) dissolved in IX 
HBSS (Ca2+- and Mg^^-free). The mixture was incubate at 37�C with shaking for 10 
min and then centrifliged at low speed (40g，5mm at 4�C) to remove undigested 
tissue debris. The supernatant was further centrifuged (700g, lOmin at 4^C) to 
precipitate the cells. The cells were washed in 1ml of PBS and transferred to an 
Eppendorf tube followed by another centrifugation (700g, 5min at 4�C). The 
supernatant was decanted and cells were resuspended with ice cold IX PBS to 1x10^ 
cells/ml. 
B. Procedures of Comet assay 
Lysis solution (about 40ml) provided by the Trevigen's CometAssay™ kit was 
chilled at or on ice for 20min before use. The provided LMAgarose was melted 
in a beaker of boiling water for 5 min, with the cap loosened. Then the bottle was 
cooled in a 37�C water bath for 20 min. The temperature of the agarose is critical or 
cells may undergo heat shock. Aliquots of the molten agarose were placed into 
prewarmed eppendorf tubes placed at 37°C water bath. The cells at the concentration 
of 1 X 1 oVml were combined with the molten LMAgarose (at 37°C) at a ratio of 1:10 
(v/v) and the mixture (75jil) was immediately pipetted onto the CometSlideTM. The 
mixture was spread over the sample area using the side of pipette tip to ensure the 
complete coverage of the area. Then the procedures were repeated for the rest of the 
samples. 
The slides were placed flat at 4°C in dark for 30min until a 0.5mm clear ring 
appears at the edge of CometSlide" '^^  area. The slides were immersed in prechilled 
Lysis Solution (from Trevigen's CometAssay™ kit) and leave at for 45min. With 
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the excess buffer was tapped off, the slides were immersed in freshly prepared 
alkaline solution, pH >13. The slides were left for 60min at room temperature in 
dark. 
C. TBE Electrophoresis 
The slides were removed from the alkaline solution, and the excess buffer was 
gently tapped off. The slides were washed by immersing in IX TBE buffer for 5min, 
2 times and then transferred to a horizontal electrophoresis apparatus. The slides 
were laid flat onto the gel tray and aligned equidistant from the electrodes. IX TBE 
buffer was poured to the tray until the slides were just covered. The power supply 
was set to 1 volt per cm (measured from electrode to electrode). The voltage was 
applied for lOmin. After electrophoresis, excess TBE buffer was gently tapped off, 
and the slides were dipped in 70% ethanol for 5min. Then the samples were air-dried. 
At this stage, the samples may be stored at room temperature with desiccant. 
Diluted SYBR® Green I (50|il) was placed onto each circle of dried agarose. 
After 15min, the slides were viewed by epifluorescence microscopy. 
D. Comet Scoring 
The image analysis system provided by our department consists of a 
epifluorescence microscope, camera and a computer analysis package (Komet™ 3.1, 
Kinetic Imaging). For each samples, at least 50 cells were randomly selected and 
scored. Comets which were near the edges or around air bubbles were not scored as 
they often display comets with anomalously high levels of damage. In addition, 
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overlapping comets were not scored. Experiment Scoring creates a Database of 
images and comet data for each cell scored. The comet data such as cell area, head 
o/oDNA，tail o/oDNA, tail length, Olive Tail Moment, L/H (tail/Head), extent tail 
moment, and comet optical intensity were produced by the software automatically. 
Statistical results were also obtained from the calculation of the software including 
the mean value, standard deviation, standard error, and the max/min value of each 
item. 
3.2.5 Statistical analyses 
The data in dose-response and hepatoprotection experiments of CCI4 and AFBi 
were analyzed by one-way ANOVA followed by Student's /-test. The mean values of 
liver per body weight, SGPT and SGOT levels of the control and treatment groups 
were compared. The results were expressed in means 土 standard deviation. 
The data from comet assay on the genetic toxicology, and the potential 
hepatoprotective effect of Ptr sclerotium against AFBi were analyzed by one-way 
ANOVA. The mean values of tail length, tail DNA (%)，and the Olive tail moment 
levels of the control and treatment groups were compared. The results were 
expressed in means 土 standard deviation. 
The results from the experiments were regarded as significance if p < 0.05. 
Once significant differences have been detected, Tukey HSD test was used as a 
post-ANOVA pair-wise comparison for the mean value among groups. 
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3.3 Results and Discussion 
The increase of the activities of SGPT and SGOT has been considered as a 
reliable index of liver damage (Wang et al., 1996). GPT may leak into serum in any 
condition that alters membrane permeability to a sufficient degree. Leakage dose not 
require cell death and elevated activity does not imply necrosis. Moreover, the 
magnitude of serum activity elevation is proportional to the number of affected 
hepatocytes and is not indicative of the reversibility of the lesion (Hall, 1992). SGOT 
activity tends to parallel SGPT activity with respect to liver damage, but it is not 
liver-specific because of their high concentrations in other tissues especially muscle 
(Hall, 1992). 
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From the biochemical and histopathological results of the acute toxicity test, the 
acute consumption of up to 75% Ptr sclerotial diet would not cause any abnormal or 
adverse changes in the liver of rats. Also, the biochemical results of the rats fed with 
20% Ptr sclerotial diet at the 45出 day of the sub-chronic toxicity test (data not shown) 
showed no abnormal changes in their body. Therefore, 20% Ptr sclerotial diet was 
used in the trial studies of hepatoprotective effect. 
The body weights of rats from the control groups in all hepatoprotection 
experiments were reduced at terminations (after fasting period) (Figure 3.7a, 3.15a). 
This was because rats that are deprived of food overnight also consume less water, 
resulting in a loss of body weight (Loeb, 1999). Therefore the body weight reduction 
of rats in the control group was considered as normal. 
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3.3.1 Curative and preventive tests of Ptr sclerotium against 
CClrinduced hepatotoxicity 
3-3.1.1 Dose-response of CCI4 on rat model 
The administration of carbon tetrachloride (CCI4) intraperitoneally into animal 
models induces acute liver injury mediated by reactive oxygen species (ROS; e.g., 
superoxide, hydroxyl radicals, peroxide) as metabolites in hepatocytes (Taniguchi et 
(2/., 2004). ROS plays a role in liver injury of various etiologies (Parola and Robino, 
2001; Gebhardt, 2002). Acute and reversible liver injury induced by CCI4 is 
transiently accompanied by significant inflammation and necrosis of hepatocytes, 
‘ i| 
followed by complete restoration with hepatocyte regeneration in the late stage of the 
injury (Taniguchi et al., 2004). After i.p. administration of a single dose of CCI4, : 
centrilobular necrosis begins to develop with the evidence of lesion by 12 h, and 
reaches a peak level by 24 h. The liver may be restored to normal within 14 days 
without the residues of necrotic tissue (Smuckler, 1975). Therefore, the 24 hours 
period was adopted as the toxicity end-point in the study. 
The i.p. administration of 0.7, 1.0 and 1.8 ml/kg CCI4 did not cause any death of 
the intoxicated rats. At very high doses, CCI4 elicits typical solvent toxicity, such as 
anesthesia, respiratory arrest and thus lethality. For example, a 100% death rate of 
Wistar rats was observed due to anaesthesia after inhalation exposure to CCI4 at 
concentration of 121600 mg/dL for 2.2 h (Adams et al, 1952). This acute toxicity is 
not immediately related to the liver. Medium to high doses cause wide-spread liver 
necrosis that can cause death within a few days. The LD50 (observed for 24 h) of 
male S.D. rats of CCI4 in com oil administered intraperitoneally was 3029 mg/kg 
body wt. (Klaassen and Plaa, 1969). This may be due to the thorough inhibition of 
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protein synthesis, severe intracellular Ca2+ sequestration, and the effect on membrane 
integrity (Boll et al., 2001a). While in mid to lower dose range of CCI4, for instance, 
30 to 1000 mg/kg body wt., toxicity is mainly due to the disturbance of lipid 
homeostasis with significantly lowered plasma concentrations of cholesterol, 
triglycerides, phospholipids and total lipid (Honma, 1990; Boll et al., 2001b). 
Without causing death of the rats at 24 h after the injection, all the three doses of 
CCI4 were suitable to be used in the curative or preventive hepatoprotection tests for 
Ptr sclerotium depending on the liver injury level needed to be induced. 
There was no difference in body weight reduction among the rats in different 
treatment groups {p > 0.05) (Figure 3.7a). | 
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The liver per body weight ratios were significantly increased in all CCU-treated 
groups analyzed by one-way ANOVA (p < 0.05) (Figure 3.7b). The highest % 
increase in liver per body weight was observed in rats intoxicated with 1.8 ml/kg 
CCI4, which was 28.47% higher {p < 0.05) than that of the control. The increase in 
liver weight (liver hypertrophy) is considered to be benign and adaptive changes in 
response to certain chemicals that stimulate the hepatic drug metabolizing enzyme 
system (Amacher et al, 1998). However, the liver weight increase is not correlated 
to the magnitude of metabolizing enzyme induction (Amacher et al., 1998). 
The administration of 1.8 ml/kg CCI4 to the rats resulted also the highest (p < 
0.05) SGPT and SGOT levels which was 45 times and 60 times, respectively higher 
than that of the control (Figure 3.7c and d). Serum transaminase activities of rats 
intoxicated with 1.0 ml/kg CCI4 were also higher (p < 0.05) than the control, 
although they were significantly lower (p < 0.05) than that of the 1.8 ml/kg. The 
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SGPT and SGOT activities of rats from the control group were only 43.21 lU/L and 
72.82 lU/L，respectively. The elevated transaminase levels were dose-dependent in 
this experiment, with non-linear relationships (Figure 3.7c and d). This indicated that 
at this range, the more the CCI4 molecules were administered, the more the reactive 
free radicals were produced by P450 metabolism to exert adverse effects to the 
hepatic cells. Taking together with the significant difference in liver per body weight, 
the significant elevation of the transaminase activities indicated that the 
administration of CCI4 at 0.7, 1.0 and 1.8 ml/kg had successfully induced liver injury 
(Figure 3.7b, c and d). From the hepatoprotective studies that involved CCI4 as a 
liver injury inducer, the dose used was commonly capable to elevate SGPT and 
SGOT activities to about 1000 lU/L and 2000 lU/L, respectively (Wong et al, 2000; 
Wong et aL, 2003; Nakahira et al., 2003; Taniguchi et al., 2004). The transaminase 
activities at this range indicate significant liver injury has been induced for 
comparing the effect between the potential protective substances to the control, 
without inducing irreversible adverse changes to the liver and its functions 
(Taniguchi et al., 2004). The results of the transaminase activities (SGPT: 500 — 1950 
lU/L; SGOT: 890 - 4422 lU/L) in the dose-response experiment (Figure 3.7c and d) 
suggested that the dose of CCI4 used in the hepatoprotective experiment between 1.0 
and 1.8 ml/kg would be suitable. Therefore, 1.5 ml/kg CCI4 was used in the 
preliminary curative hepatoprotective experiments. 
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Fig. 3.7 Effect of different doses of CCI4 to a) body weight reduce (%), b) liver per 
body weight (g/kg), c) SGPT and d) SGOT levels (lU/L) of the rats. Each value 
represents the mean 士 standard deviation (n = 4). Bars with significant difference 
were indicated by different alphabets (one-way ANOVA, Tukey, p < 0.05). One 
International Unit (lU) of SGPT/SGOT is defined as the amount of transaminase that 
oxidizes one micromole of NADH per minute. 
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3.3.1.2 Curative test of Ptr sclerotium against CCU-induced 
hepatotoxicity 
The administration of 1.5 ml/kg CCI4 had elevated the SGPT and SGOT 
activities (Figure 3.8) 40.5 and 30.7 times above the upper normal range in rats 
(SGPT: 30.2 IU/L; SGOT: 80.8 IU/L) (Semler et al, 1992) after 24 h. This suggested 
that the model had successfully induced liver injury (Figure 3.8). Although, the 
SGPT and SGOT activities of the rats after 24 h feeding with 30% sclerotial diet 
were lower than that of rats fed with the control diet, there were no significant 
differences (Figure 3.8). The variation of SGPT and SGOT activities among the rats 
in the control or Ptr sclerotial diet group might be due to the time of diet 
consumption as there was no fasting before the collection of blood. It had been 
reported that the elevation of SGPT activity 12 h after the administration of CCI4 was 
enhanced by fasting as compared to fed-rat (Shimuzu et al., 1989). Another literature 
reported an exposure of fed and fasted rats to 114 ppm CCI4 vapour for 6 h increased 
SGPT and SGOT activities only in fasted rats (Siegers et al., 1982), which indicated 
a higher susceptibility of CCI4. In normal livers, prolonged fasting is known to affect 
the antioxidant capacity of the cell (Martensson, 1986) because of the lack of 
cysteine and precursor amino acids for the glutathione (GSH) synthesis (Shimizu and 
Morita，1992). Therefore, the extent of elevation of SGPT and SGOT activities 
induced by CCI4 might vary with the time of diet consumption. 
After 4 days feeding period of the control or 30% Ptr sclerotial diet, the serum 
transaminase levels of rats from both group dropped back to the normal range 
(Figure 3.8). SGPT and SGOT activities of Ptr sclerotial diet fed group were not 
significantly different from that of the CCI4 control group at 24 h after CCI4 
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administration and at termination (Figure 3.8). After a single injection of CCI4, the 
release of GPT and GOT from the cytoplasm into the blood circulation is rapid due 
to the rupture of the plasma membrane and cellular damage (Sallie et al, 1991). 
After cellular damage, restoration with hepatocyte regeneration will be followed with 
the evidence of the up-regulation of the expression of representative genes 
responsible for liver function such as catalase, albumin and aldolase B at 48 h after 
CCI4 injection (Taniguchi et al, 2004). The transaminase levels had been reported to 
be identical to the control values 72 h after the i.p. administration of 0.75 ml/kg CCI4 
in female rats while that of male rats remained increasing (Smejkalova et al, 1985). 
In the present experiment, the SGPT and SGOT activites of the control group 
returned to the normal range of rat (Semler et al, 1992) 4 days after CCI4 injection 
(Figure 3.8). This suggested that the adverse effect of CCI4 to the damage of 
hepatocytes was only transient and the indication of liver injury by SGPT and SGOT 
would be useful only in acute toxicity test. 
The mean liver per body weight of the 30% Ptr sclerotial diet group was 
significantly lowered by 12.60% {p < 0.05) compared to that of the CCI4 control 
group at termination (Figure 3.9). As in other hepatoprotection studies, the 
administration of CCI4 would increase the liver per body weight ratio (Iglesia et al., 
1982; Wong, 2000). After 4 days consumption of corresponding diet, the rats from 
the 30% Ptr sclerotial group showed a significantly lower liver per body weight ratio 
than that from the control group (Figure 3.9). This suggested that 30% Ptr sclerotial 
diet had significant reduction in the liver enlargement caused by CCI4 administration. 
From the histopathological studies, restored structures could be seen in liver 
section of rats from the control group with low frequency of fatty accumulation and 
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vacuolation in hepatocytes (Figure 3.10). In comparison to that of the control group, 
liver sections of rats fed with 30% Ptr sclerotial diet showed intact and normal 
hepatocytes. No fatty accumulation or vacuolation were found in hepatic cells. 
Mitotic figures found were evidence of regeneration of hepatic cells (Wong, 2000). 
The liver of rats in 30% Ptr sclerotial diet group showed more recovery than that of 
the control diet group (Figure 3.10). In the present study, the results of 
histopathological studies were consistent with detected transaminase activities 
(Figure 3.8) which were also comparable to normal range of rats (SGPT: 17.5-30.2 
lU/L; SGOT: 45.7-80.8 lU/L) (Semler et al, 1992). It was known that liver could 
recover to normal after a single injection of CCI4 within 14 days (Recknagel et al, 
1974; Smuckler, 1975). There were mild adverse changes remained in hepatocytes 4 
days after the administration of 1.5 ml/kg CCU in the present experiment. It can be 
concluded that the consumption of 30% sclerotial diet during the 4 d experiment had 
shortened the recovery time as compared to the consumption of control diet. 
Mushrooms or plants might exert their hepatoprotective effect by promoting cellular 
mitosis action for the repair of the liver cells (Ooi, 1996; Wong, 2000). Likewise, the 
curative action on hepatic injury by the Ptr sclerotium may have been due to the aid 
in recovery or regeneration of liver cells. 
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Fig. 3.8 The serum transaminase levels of 1.5 ml/kg CCU-intoxicated rats control 
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Fig. 3.9 Liver per body weight (g/kg) of 1.5 ml/kg CCU-intoxicated rats control or 
30% Ptr sclerotial diets fed at the end of 4 days. Each value represents the mean 土 
standard deviation (n = 4). Bars with significant difference were indicated by 




Fig. 3.10 Micrographs of rats in the Ptr sclerotium curative protection test, 
administered with 1.5 ml/kg CCI4 and followed by 4 days feeding with a) control diet, 
with fatty accumulation in some hepatocytes (arrows) and vacuolation (dotted-line 
arrow); b) 30% sclerotial diet, in which fatty accumulation and vacuolation were less 
evident. CV, central vein. MF, mitotic figure. 
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3.3.1.3 Preventive test of Ptr sclerotium against CCU-induced 
hepatotoxicity 
In the preliminary preventive hepatoprotective test of Ptr sclerotium, 1.5 ml/kg 
CCI4 was used to induce liver injury. However, it was noticed that the SGPT and 
SGOT activities from the CCI4 control group and the Ptr sclerotial group were both 
very high without statistical differences (SGPT: 1999 土 459 lU/L and 1855 土 556 
lU/L; SGOT: 4188 士 787 lU/L and 4905 土 614 lU/L, respectively). The induced liver 
injury might be too high for the preventive protection of Ptr sclerotium to occur. 
Figure 3.7c and d showed that the SGPT and SGOT activities of rats intoxicated with 
0.7 ml/kg CCI4 were equivalent to 13.8% and 12.7% of that with 1.5 ml/kg CCI4. 
Therefore, 0.7 ml/kg CCI4, the lowest tested dose in the dose-response experiment, 
was used in the preventive hepatoprotection test. 
In the preventive hepatoprotective tests of Ptr sclerotium, SGPT (121.1 — 168.8 
lU/L) and SGOT (347.1 — 467.5 lU/L) activities of the CCI4 controls were elevated 
24 h after the administration of 0.7 ml/kg CCI4 (Figure 3.12 and 3.14) as compared to 
the normal range of rats (SGPT: 17.5-30.2 lU/L; SGOT: 45.7-80.8 lU/L) (Semler et 
al, 1992). 
A. 20% Ptr sclerotial diet 
The liver per body weight of rats from the 20% Ptr sclerotial diet group was 
7.O0/0 lower than that of the control, though there was no significant difference 
(Figure 3.11). The 7-day feeding of the 20% Ptr sclerotial diet had also lowered the 
SGPT and SGOT activities by 24.4% and 12.1%, respectively in the rats but the 
121 
differences were not significant (Figure 3.12). 
The 7-day feeding of 20% Ptr sclerotial diet showed no significant preventive ‘ 
hepatoprotective effect on rats intoxicated with 0.7 ml/kg CCU. There was a trend of 
lowering liver injury by the 20% Ptr sclerotial diet against CCU in terms of the liver 
per body weight and serum transaminase activities evaluated. It was believed that the 
concentration of Ptr sclerotium in the diet was not high enough for protective effect 
to occur significantly, therefore in the next experiment, 30% Ptr sclerotial diet was 
tested. 
B. 30% Ptr sclerotial diet 
The feeding of 30% Ptr sclerotial diet for one week before the administration of 
CCI4 had significantly reduced (p = 0.046) the SGOT activity by 6.66% as compared 
to that of the CCI4 control group. Lower SGPT activity was detected, but there was 
no significant difference (p = 0.079) which might be due to the relatively large 
standard deviation (Figure 3.14). The liver per body weight ratios of the CCI4 control 
and 30% sclerotial diet group had no significant difference (p > 0.05) (Figure 3.13). 
These results suggested that preventive hepatoprotective effect of 30% Ptr 
sclerotial diet against CCI4 might be marginal. It has been claimed that 
polysaccharide isolated from Ptr sclerotium could protect liver against CCU-induced 
injury indicated by its significant effect on lowering elevated SGPT activity (Huang 
and Hu, 2000). The results of the present study were not contradictory to that of the 
previous study on the hepatoprotection and immunologic function of isolated Ptr 
sclerotial polysaccharide (Huang and Hu, 2000). Although oral route was used in 
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both experiments’ the accessibility of polysaccharide in the 30% Ptr sclerotial diet 
was probably lower than that of the isolated Ptr sclerotial polysaccharide used 
previous experiments (Huang and Hu，2000). This was because the polysaccharide in 
the Ptr sclerotial was remained in the intact fungal cells in the 30% Ptr sclerotial diet. 
Therefore, the protective effect from the Ptr sclerotial polysaccharide depended on its 
release from the digestion of sclerotium which had a very low efficiency because of 
the indigestibility of fungal cell walls. The composition and preparation method of 
the Ptr polysaccharide in previous study were not defined (Huang and Hu, 2000), 
therefore the protective effect towards the liver was difficult to be compared with 
that of the present 30% Ptr sclerotial diet. CCI4 was activated by cytochrome P450 
system in the endoplasmic reticulum of the hepatocytes to the reactive metabolite, 
CCI3-. This radical can form covalent products with protein and lipid by interacting 
with O2 to generate CCI3O2 which in turn initiates lipid peroxidation of the 
endoplasmic reticulum (Recknagel et al” 1989; Gilani and Janbazz, 1995; WHO, 
1999). These cause the disintegration of lysosomal, mitochondrial and cellular 
membranes and lead finally to cell necrosis (Slater, 1972; Recknagel et al., 1982). 
The increases in SGPT and SGOT activities have been attributed to damage to the 
structural integrity of the liver (Chenoweth and Hake, 1962). The Ptr sclerotium 
polysaccharide probably exerted its hepatoprotective effect by preserving the 
structural integrity of the plasma cellular membrane of the hepatocytes and/or 
scavenging products of CCI4 metabolization such as CCI3', superoxide and alkoxy 
radicals (Ooi, 1996) preventing the start of lipid peroxidation and the following 
cascade of cellular damages. 
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Fig. 3.11 Liver per body weight (g/kg) of 0.7 ml/kg CCU-intoxicated rats after 7 
days feeding of control or 20% Ptr sclerotial diet in the preventive hepatoprotection 
test. Each value represents the mean 土 standard deviation (n = 4). 
600 p - - — ; , r — — — ” T I. 
,‘；'、…：� / z & ‘‘ '> 
0 Control diet 丁 
500 “ ^ - ^ ― — 
• 20% sclerotial diet pto^^j^wss T 
� ~ ‘ t? I I 
5 400 ••••• r；-广 "〒‘•， '”.、 '’广 '〜. '， '’霧德’— 1 
300 , , ‘ mMk^^mn 
r ^^^^^^^•； 
ES r + i T k • ' 
I 上 ] L -
M l — — 々 • 
0 I ^ . “ • • - y 
SGPT SGOT 
Fig. 3.12 Serum transaminase levels of 0.7 ml/kg CCU-intoxicated rats after 7 days 
feeding of control or 20% Ptr sclerotial diet in the preventive hepatoprotection test. 
Bars with significant difference were indicated by different alphabets (Student's /-test, 
p < 0.05). One International Unit (lU) of SGPT/SGOT is defined as the amount of 
transaminase that oxidizes one micromole of NADH per minute. 
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Fig. 3.14 Serum transaminase level of 0.7 ml/kg CCU-intoxicated rats after 7 days 
feeding of control or 30% Ptr sclerotial diet in the preventive hepatoprotection test. 
Bars with significant difference were indicated by different alphabets (Student's /-test, 
p < 0.05). One International Unit (lU) of SGPT/SGOT is defined as the amount of 
transaminase that oxidizes one micromole of NADH per minute. 
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3.3.2 Preventive tests of Ptr sclerotium against 
AFBi-induced hepato- and geno-toxicity 
3.3.2.1 Dose-response of AFBi on rat model 
Aflatoxin Bi is highly potent in the induction of acute toxicity in animals and in 
humans. The liver is the prime target organ of AFBi for acute toxicity and 
carcinogenicity in animals (Stark, 2001). The LD50 of AFBi of infant S.D. rats (aged 
1 d) was 1.36 mg/kg by p.o. administration (Hayes et al, 1977). A single high dose 
(10 mg/kg) of AFBi by gavage led to 83% mortality in rats, while a lower acute dose 
(4 mg/kg) induced 33% mortality (Kensler et al., 1992). Much of aflatoxin 
biotransformation research has been focused on the formation of metabolites that are 
capable of reacting with DNA, which related to the carcinogenicity of aflatoxins. 
Rather less attention has been given to the role of biotransformation in acute 
aflatoxin toxicity (Eaton et al, 1994). Whilst carcinogenicity and mutagenicity of 
AFBi are associated with the DNA binding properties of its metabolites (Stark et al, 
1979; Stark and Giroux, 1983), the acute AFBi toxicity may also be associated with 
the aflatoxins-protein binding (McLean and Dutton, 1995). In acute AFBi toxicity, 
DNA and RNA syntheses are rapidly inhibited. Although protein synthesis, 
mitochondrial electron transport, and lipid biosynthesis are also inhibited, the 
inhibition is not as rapidly or as extensively as that of the nucleic acids (Busby and 
Wogan, 1984). Ingestion of aflatoxins (AF) led to the breakdown of lysosomes in 
parenchymal liver cells and the release of degradative enzymes. The latter caused 
acute damage to the liver (hemorrhage and necrosis) (Busby and Wogan, 1984). It 
was observed that liver parenchymal cell mitosis was decreased dramatically within 
the first day after AFBi administraton (Busby and Wogan, 1984). AFB, is also an 
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immunosuppressor in rats (Raisuddin et al., 1994) due to its capability to impair 
DNA, RNA and protein synthesis. Actively dividing cells such as those of the 
immune system are thus sensitive to theses effects more than non-dividing ones 
(Stark, 2001). Moreover, the metabolic process of aflatoxin Bi by cytochrome P450 
elevated ROS level in AFB,-treated hepatocytes (Shen et al., 1996). The enhanced 
level of ROS may be responsible for the oxidative damage caused by AFBi, which 
may ultimately contribute to the cytotoxic and carcinogenic effects of AFBi (Shen et 
a/., 1996). AFBi can cause lipid peroxidation in rat liver (Shen et al., 1994). 
Oxidative damages caused by AFBi may be one of the underlining mechanisms for 
AFBi-induced cell injury and DNA damage (Shen et al, 1994). In vivo 
administration of AFBi had been shown to significantly elevate SGPT and SGOT 
activities in single or sub-chronic dosing (7 mg/kg i.p. and 0.4 mg/kg i.g” 
respectively) (Dwivedi et al., 1993; Liu et al, 2001). 
Covalent binding of aflatoxin to nucleic acids occurs within minutes of 
treatment of rats with AFBi, which results in a precipitous decrease in both DNA and 
RNA synthesis rates in the liver. Also, protein synthesis declines within 1 h after 
AFBi exposure (Busby and Wogan, 1984). In the present experiment, significant 
adverse changes of body weight, SGPT and SGOT activities, and DNA damages 
were induced by AFBj at 0.7，1.0 and 1.5 mg/kg in rats after 24 h (Table 3.15a, c and 
d). These changes were AFBi dose-dependent. The higher the dose of AFBi 
administered, the higher the adverse effect. 
In the present study, the i.p. administration of 0.7, 1.0 and 1.5 mg/kg AFBi did 
not cause any death of the intoxicated rats. However, the administration of 1.0 and 
1.5 mg/kg AFBi led to significant reduction in body weight of the rats as compared 
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to that of the control group one day after the intoxication (p < 0.05) (Figure 3.15a). 
The highest body weight reduction was observed in 1.5 mg/kg AFBi which was 
80.47% more than that of the control. 
There was no difference in liver per body weight between rats from different 
groups (p >0.05) (Figure 3.15b). The liver per body weight ratio of the AFBi treated 
groups did not show any significant difference (Figure 3.15b). Nevertheless, there 
was a decreasing trend in the liver per body weight ratio observed in the control, 0.7 
and 1.0 mg/kg AFBi. Rats administered with 1.5 mg/kg AFBi showed similar liver 
per body weight ratio with that from the control group (Figure 3.15b). This might be 
considered as a different response of the liver to the very high dose (> 1.5 mg/kg) of 
AFBi in which a different mechanism might be triggered in the metabolism. 
The SGPT levels in all AFBi-treated groups were significantly higher than that 
of the control group (Figure 3.15c)，while only the group of rats administered with 
1.0 and 1.5 mg/kg AFBi showed statistical differences (p < 0.05) in SGOT level to 
the control group (Figure 3.15d). The highest serum transaminase activities were 
observed in rats intoxicated with 1.5 mg/kg AFBi, in which SGPT was elevated by 
74 times and SGOT was elevated by 48 to that of the control ones. The lowest AFBi 
dose, 0.7 mg/kg, tested in this experiment induced severe liver injury as indicated by 
the significantly elevated SGPT and SGOT activities (Figure 3.15c and d) which 
were comparable to that induced by 1.5 ml/kg CCI4 (Figure 3.7c and d) administered 
by the same route, i.p.. In addition, the effect on serum transaminase activities was 
consistent with that on DNA damage (Tail DNA %) evaluated by comet assay 
(Figure 3.16). 
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It has been shown that AFB 丨 intoxication in vivo induces DNA damage detected 
by comet assay (Abd-Allah et al., 1999; Miyata et al., 2004). In the present 
experiment, significant increase of tail length, tail DNA % and olive tail moment 
were detected in the hepatic nuclei of AFB,-intoxicated rats at all 3 tested doses 
(Figure 3.10, table 3.1). All 3 parameters showed dose-dependent adverse effect to 
hepatic DNA induced by AFBi. 
The rats administered with 1.0 and 1.5 mg/kg AFBi showed significant liver 
DNA damage (p < 0.05, one-way ANOVA) in terms of tail DNA % as compared to 
that of rats in the control group (Figure 3.16). Rats from 1.5 mg/kg AFBi induced the 
highest tail DNA %, which was 3 times higher than that of the control. In the present 
experiment, tail DNA % of hepatic nuclei from rats administered with 1.5 mg/kg 
AFBi was significantly higher than that with 1.0 mg/kg (Figure 3.16). Figure 3.17 
showed the appearances of hepatic nuclei captured in comet assay. The 
administration of different doses of AFBi had induced different extent of tail DNA 
migration from the nuclei. The present results indicated that cell injury as well as 
DNA damage of the hepatocytes of rats was successfully induced by AFBi. 
Tail lengths of liver nuclei of rats administered with 1.0 and 1.5 mg/kg AFBj 
were not significantly different analyzed by one-way ANOVA (p > 0.05), but were 
significantly different from that of control (p < 0.05) (Table 3.1). Tail length of liver 
cell nuclei, measured as an indicator of DNA damage, has been reported to be 
significantly increased in rats administered with 5 mg/kg AFBi (Miyata et al., 2004). 
The values of tail length of rats intoxicated with 1.0 and 1.5 mg/kg AFBi showed no 
significant difference to each other. Tail length is commonly used in Comet studies 
and is generally believed to be related directly to fragment size and would be 
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expected to be proportional to the level of SSB and ALS (Tice, et al., 2000). 
However，it has been reported that the length of DNA migration reached a plateau 
while the percentage of migrated DNA continued to increase in neutral or alkaline 
(pH 12.3) assays (Olive et al, 1992). This is because the length of comet tail depends 
only on the size of the smallest fragment, while DNA percentage accounts the 
amount of DNA fragment produced. Tail length cannot distinguish samples with 
different amount DNA fragment but only the same range of fragment size. Therefore, 
the utilization of the length of DNA migration in expressing the extent of DNA 
damage was not desirable in high doses of AFBi intoxication. However, when using 
a derived metric such as tail moment, data on tail length and the percentage of 
migrated DNA should also be provided (Tice et al., 2000). Olive tail moment of rats 
administered with either 1.0 or 1.5 mg/kg AFB, also showed significant difference to 
that of the control {p < 0.05) (Table 3.1). 
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Fig. 3.15 Effect of different doses of AFBi to a) body weight reduction (%), b) liver 
per body weight (g/kg), c) SGPT and d) SGOT levels (IU/L) of the rats. Significant 
differences were found between the control and AFBi treatment groups in body 
weight reduce and serum transaminase levels. Each value represents the mean 土 
standard deviation (n = 4). Bars with significant difference were indicated by 
different alphabets (one-way ANOVA, Tukey HSD, p < 0.05). One International Unit 
(lU) of SGPT/SGOT is defined as the amount of transaminase that oxidizes one 
micromole ofNADH per minute. 
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Fig. 3.16 Effect of different doses of AFBi on DNA damage to liver cells of rats. 
Each value represents the mean 士 standard deviation of 4 treated rats. Bars with 
significant difference were indicated by different alphabets (p < 0.05) analyzed by 
one-way ANOVA and Tukey HSD. 
Table 3.1 DNA damage by different doses of AFBi on of the rat liver cells. 
Control 0.7 mg/kg 1.0 mg/kg 1.5 mg/kg 
Tail length (|im) 31.28±5.388' 36.89±3.630'^ 43.04±5.075'' 47.22±6.644^ 
Olive tail 1.915+0.3785' 3.394±0.6483'^ 4.104±1.16lb 7.305土 1.256" 
moment (jam) 
Data are means 士 standard deviation. The mean values within the same column with 





Fig. 3.17 Micrographs showing different extent of DNA migration of hepatic nuclei 
of rats from a) control group, with almost no tail intact nucleus and intense 
brightness at the center indicating that DNA content was well confined in nucleus; b) 
0.7 mg/kg AFBi group with low DNA migration from the nucleus; c) 1.0 mg/kg 
AFBi group with medium length of DNA migration, d) 1.5 mg/kg AFBi group with 
medium length but higher intensity of DNA tail than that of 1.0 mg/kg AFBi group. 
Magnification: 200x 
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3.3.2.2 Preventive test of Ptr sclerotium against AFB,-induced geno-
and hepatotoxicity 
A number of edible substances and/or their extracts have been demonstrated to 
possess hepatoprotective effect against AFB! in vivo, which included grape fruit juice, 
garlic, Salvia miltiorrhiza (a traditional Chinese medicine), Egletes viscosa L. (a 
small medicinal herb) and capsaicin (a kind of spices) (Ted, 1991; Souza et al., 1999; 
Liu et al； 2001; Berges et al., 2004; Miyata et al., 2004). The mechanisms of 
hepatoprotective effect of these substances against AFBi have been investigated and 
considerable proportions have been found to have antioxidant properties. More 
recently, molecular investigations demonstrated that regulations on the phase I and II 
enzymes contributed to the protective effect of these chemopreventive agents 
(Manson et al, 1997; Souza et al, 1999; Liu et al, 2001; Lu and Li, 2002). 
The administration of 0.7 mg/kg AFBi had significantly reduction in the body 
weight and liver per body weight ratio of the rats than the control group (Figure 
3.18a and b). Rats intoxicated with 0.7 mg/kg AFBi had 6.75 times higher body 
weight reduction and 24.76% liver per body weight reduction in comparison to that 
of the control. The rats fed with 30% Ptr sclerotial diet one week before the 
administration with the same AFBi dose showed a significant increase (15.54%; p < 
0.05) of liver per body weight ratio than that of the AFBi control group, although this 
value was still significantly lower than that of the control group without AFBi 
intoxication (p < 0.05). The liver per body weight value of the CHL positive control 
group fell between that of the AFBi control and 30% Ptr sclerotial diet group 
showing no significant differences. 
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The liver injury indicators, SGPT and SGOT were significantly elevated in rats 
from the AFB, control group (Figure 3.18c and d). The SGPT levels of rats from the 
Ptr sclerotial diet and CHL positive control group were not different from that of the 
control group {p < 0.05). In comparison to AFB, control group, 30% Ptr sclerotial 
group and CHL positive control group had significantly lowered AFB,-induced 
SGPT activity by 64.02% and 84.50%, respectively (Figure 3.18c). The SGOT level 
of rats from the Ptr sclerotial diet group was significantly lower (p < 0.05) than that 
from the AFB 丨 control group but still significantly higher (p < 0.05) than that of the 
control group (Figure 3.18d). The SGOT level of rats from the CHL positive control 
group was not different from that of the control group. The Ptr sclerotial diet and 
CHL positive control had reduced significantly the SGOT activity of the AFB, 
control by 54.61% and 83.19%, respectively (Figure 3.18d). 
Although there was no significant different analyzed by one-way ANOVA, the 
SGPT activity of rats from 30% Ptr sclerotial diet was 2.3 times higher than that of 
rats from the CHL positive control group, the SGPT activity of the CHL positive 
control group was reduced by 84.5% compared to that of the AFB, control group, 
while the reduction of one-week-feeding of 30% Ptr sclerotial diet was 64.0%. Also, 
the SGOT activity of rats from CHL positive control group was comparable to the 
control group and was significantly lower (p < 0.05) than that of rats from 30% Ptr 
sclerotial diet (Figure 3.18d). The reduction in SGOT activity induced by 0.7 mg/kg 
AFBi by CHL and 30% Ptr sclerotial diet were 83.2% and 54.6%, respectively. 
Results from these biochemical assays suggested that the co-administration of 10 
mg/kg CHL with AFBi might be more effective in the protection of hepatic cells than 
the one-week-feeding of 30% Ptr sclerotial diet against 0.7 mg/kg AFB, i.p. 
administration. 
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In the present study, the body weight reduction of rats from AFB, control, Ptr 
sclerotial diet and CHL positive control groups were significantly higher than that of 
the control group, although significant suppression of SGPT and SGOT activities 
was found in the rats treated with 30% Ptr sclerotial diet and CHL positive group 
(Figure 3.18a, c and d). Consistent result was obtained from the detection of DNA 
breakages by comet assay in which the extent of DNA damage of rats induced by 
AFBi in 30% Ptr sclerotial diet and CHL positive control group were significantly 
lower than the AFBi control group (Figure 3.19; Table 3.2). 
From the present results, the administration of 10 mg/kg CHL immediately after 
that of AFBi (0.7 mg/kg) had significantly lowered the activities of SGPT and SGOT, 
and decreased the extent of DNA damage to rat hepatocytes expressed as tail DNA 
(o/o) and olive tail moment in comparison to AFBi control (Figure 3.19, table 3.2). 
The one-week-feeding of 30% Ptr sclerotial diet had also protected the rats from 
AFBi-induced hepato- and genotoxicity to a certain extent. Thirty percent Ptr 
sclerotial diet significantly reduced the degree of liver per body weight reduction， 
lowered SGPT and SGOT levels, and decreased tail DNA % and olive tail moment 
which were induced by AFB, as compared to the control (Figure 3.18b, c, d and 
3.19). 
The administration of 0.7 mg/kg AFBi had significantly induced 2.87 times 
higher tail DNA percentage than the control group (p < 0.05) (Figure 3.19). 30% Ptr 
sclerotial diet and the co-administration of CHL had significantly lowered the 
AFBi-elevated tail DNA percentage by 37.42% and 39.22% (p < 0.05) compared to 
AFBi control (Figure 3.19). The tail length and olive tail moment of AFBi control 
group were significantly higher than that of control group (p < 0.05) (Table 3.2). 
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Although 30% Ptr sclerotial diet and CHL positive control group had lowered 
AFBi-increased tail length, there were no differences as compared to the AFBi 
control {p > 0.05). Olive tail moments of 30% Ptr sclerotial diet and CHL positive 
control groups were significantly lower than that of the AFBi control group {p < 
0.05)，and were not different from that of the control group {p > 0.05). Ptr sclerotial 
diet and CHL co-administration had reduced the AFBi-elevated olive tail moment by 
43.24% and 44.81%, respectively. 
The genoprotective effect of 30% Ptr sclerotial diet was comparable to that of 
CHL. 30% Ptr sclerotial diet had reduced tail DNA % induced by AFBi by 37.4% 
while the co-administration of CHL and AFB! had reduced the tail DNA % by 39.2%. 
This suggested that the genoprotective effects in terms of preventing DNA breakages 
in hepatic cells after the one-week-feeding of 30% Ptr sclerotial diet before 
administration of AFBi, and the co-administration of 10 mg/kg CHL with AFBi were 
at similar level. 
3.3.2.3 CHL versus 30% Ptr sclerotial diet 
It was reported that the concurrent oral treatment of rats with 100 mg of CHL 
and 10 ^g of AFBi led to 45-50% reductions in the levels of aflatoxin-DNA adducts 
in liver and overall excretion of aflatoxin equivalents in urine (Kensler et al., 1998). 
In addition, CHL dose-dependently inhibited the covalent binding of AFBi to liver 
DNA when they were co-administered in the diet (Dashwood et al., 1991). When 
CHL was given in the diet and AFBi was administered by i.p., the protection was less 
effective suggesting that the direct interaction in the gut was needed (Dashwood et 
al, 1991). In another study of fish model, the co-exposure of 0.1 ppm AFBi and 500 
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ppm CHL resulted in reduced hepatic AFB,-DNA adduction by 95%, sequestering 
>990/0 of AFB, as the CHL:AFB, complex and reduced hepatocarcinogenesis 
compared with exposure to AFB, alone (Breinholt, 1999). Meanwhile, the 
pretreatment of dietary CHL given prior to AFBi exposure via gill uptake of fish 
resulted in no detectable lowering effect on the level of AFBi-DNA adducts or final 
tumor incidence. It has been proposed that the CHL:AFBi complex formation and 
reduced systemic AFB, bioavailability is the principal mechanism for CHL 
chemoprevention and that in situ target organ inhibitory mechanisms are relatively 
insignificant (Breinholt et al., 1999). The results of CHL positive control of this 
experiment also agreed with the above hypothesis that CHL may act as an 
‘interceptor molecule, forming complex with AFBi (Hartman and Shankel, 1990). As 
a result, CHL reduced the adverse effects of AFBi on hepatocytes and their DNA 
content by reducing its bioavailability. 
In the present experimental design, Ptr sclerotium entered the body of rat 
through gastrointestinal tract while AFB, entered intraperitoneally. The 
one-week-feeding allowed Ptr sclerotium to accumulate or exerting its effect in the 
liver, if any. Since the routes of entering the liver for Ptr sclerotium and AFBi were 
different, a direct complex formation between them before entering the liver was not 
possible. There could be several ways for Ptr sclerotium to exert its protective effect 
to hepatic cells in the present experiment. Ptr sclerotium could have provided 
protection only if its concentrations in hepatic cells were sufficient to 1) inhibit the 
bioactivating enzymes, such as CYP2K1 and CYP3A2 (which would reduce 
8,9-epoxide formation); 2) elevate detoxication enzymes, such as glutathione 
transferase or UDP-glucuronosyl transferase; 3) form complex with AFBi in the cells; 
or 4) scavenge 8,9-epoxide intermediate (Breinholt et al., 1999). As no experiment 
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has been done at the molecular level, the exact protective mechanism of Ptr 
sclerotium against AFB, is still unclear. Also, as the whole Ptr sclerotium was used in 
the experiments, the bioactive components contributed to the protective effect have 
not been identified yet. 
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Fig. 3.18 Effect of Ptr sclerotial diet and CHL on AFBi-induced hepatotoxicity to 
rats in terms of a) body weight reduction (%), b) liver per body weight (g/kg), c) 
SGPT level (lU/L) and d) SGOT level (lU/L). Each value represents the mean 士 
standard deviation of 4 treated rats. Bars with significant difference were indicated 
by different alphabets (one-way ANOVA, Tukey HSD, p < 0.05). One International 
Unit (lU) of SGPT/SGOT is defined as the amount of transaminase that oxidizes one 
micromole of NADH per minute. 
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Fig. 3.19 Effect of Ptr sclerotial diet and CHL on AFBi-induced DNA damage to rat 
liver cells as tail DNA (%). Each value represents the mean 土 standard deviation of 4 
treated rats. Bars with significant difference were indicated by different alphabets 
(one-way ANOVA, Tukey HSD, p < 0.05). 
Table 3.2 Effect of Ptr sclerotial diet and CHL on DNA damage induced by AFBi 
on rat liver cells. 
Ptr sclerotial 
Control AFB i control CHL + AFB i 
diet + AFBi 
Tail length (^m) 27.47±1.924' 39.52±3.260^ 37.54±2.958^ 35.41士3.301匕 
Olive tail . ^ 
1.52110.3088' 6.365±1.909b 3.613±0.4956' 3.513±0.3872' 
moment (jim) 
Data are means 士 standard deviation. The mean values within the same column with 
different superscripts were significantly different at /> < 0.05 (one-way ANOVA, 
Tukey HSD). 
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3.3.3 A comparison of the hepatotoxicity of CCI4 and AFBi 
The toxins, CCI4 and AFB! used in this research have several aspects in 
common in exerting their toxic effect to cells. In both cases, it is not the parent 
compounds that confer toxicity on a cell, but rather one or several of their 
metabolites. The enterance of these xenobiotics triggered a series of reaction that 
lead to their removal out of the body of rats. Both CCI4 and AFB, are lipophilic in 
nature and required to be enzymatically converted (biotransformation) into more 
hydrophilic compounds before they can be readily excreted in the urine (Boelsterli, 
2003). Biotransformation consisted of two major pathways: phase I metabolism in 
which a functional group is added or cleaved; and phase II metabolism in which the 
xenobiotics or its metabolite is coupled with an endogenous substrate (conjugation) 
(Boelsterli, 2003). Instead of detoxification, CCI4 and AFB! are converted into more 
reactive and more toxic species and this metabolic step is called bioactivation. 
Cytochrome P450 (CYP, P450) is found predominantly in the liver, and is the most 
important enzyme family in oxidative, reductive, and peroxidative biotransformation 
of many endogenous and exogenous compounds. In particular, CYPl, 2 and 3 play 
an important role in mediating bioinactivation, bioactivation, and toxicity of the 
xenobiotics (Boelsterli, 2003). The overall function of CYP is that of a 
monooxygenase which inserts one atom of oxygen into a substrate (oxygenation). It 
had been reported that both CCI4 and AFBi were activated by cytochrome P450 
(Hodgson, 2004) and resulted in reactive oxygen species (Liu et al., 2001; Ulicna et 
a/., 2003). CCI4, a well-known model compound for producing chemical hepatic 
injury, requires biotransformation by the P450 to produce hepatotoxic metabolites, 
namely trichloromethyl free radicals ('CCI3 and/or CCI3OO') (Recknagel et al., 1989; 
Williams and Burk, 1990; Boll et al” 2001). On the other hand, AFB, is converted 
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into aflatoxin B, 8,9-epoxide (AFBO) by P450 (Stark, 2001; Boelsterli, 2003). The 
expressions of CYPs are tightly regulated and in most cases, the regulation is 
transcriptional. The enhanced expression of CYPs activities can greatly augment the 
bioinactivationZ-activation rates of the xenobiotics (Boelsterli, 2003). Although 
several isoforms of P450 can metabolize CCI4, most attention has been focused on 
the P450 2E1 isoform, which is ethanol inducible (Koop, 1992; Zangar et al., 2000; 
Lee et al., 2004). It had been claimed that the suppression of P450 2E1 activity can 
reduce the hepatic injury from CCI4 (Lee et al., 2004; Tasduq et al., 2005). For AFBi, 
there is evidence that CYP3A2 and CYP2C11 were involved in the production of 
AFBO in rats (Shimada et al., 1987; Imaoka et al., 1992) and that grape fruit juice 
suppressed hepatic CYP3A activity. 
In phase II metabolism, conjugation of CCI4 and AFB! metabolites to 
glutathione (GSH) is an important mechanism in their detoxification pathways 
(Hayes et al., 1991; Boelsterli, 2003; Fukao et al” 2003). The conjugation 
inactivates the active and potentially dangerous metabolites and enables renal 
excretion of the xenobiotics (Boelsterli, 2003). The central biological property of 
GSH is the cysteine residue with the reactive S-H group. Glutathione-S-transferase 
(GST) is a family of enzymes catalyzing the transfer of GSH to a broad variety of 
xenobiotics. GST can also be induced by xenobiotics. Often, GST is induced by 
compounds that produces reactive metabolites which are then detoxified by GST 
(Boelsterli, 2003). The trichloromethyl free radicals can react with sulfhydryl groups 
such as that in the GSH. This prevents the covalent binding of the trichloromethyl 
free radicals to the cell proteins, which is considered to be the initial step in a chain 
of events that lead to membrane lipid peroxidation (Recknagel et al., 1991; Brent 
and Rumack, 1993). GST can catalyze the rapid inactivation of aflatoxin B-
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1-8,9-epoxide by glutathione-S-conjugation. A striking species difference in GSH 
conjugation of AFB丨-8，9-epoxide has been observed between mouse and rat 
(Monroe and Eaton, 1987; Quinn et al., 1990). Although the mouse has very high 
microsomal AFB, epoxidation activity (Monroe and Eaton, 1987), the species is 
very resistant to AFBi induction of tumors. It is the most plausible that the 100-fold 
higher activity of GST-A (sub-family of GST) of mice which results in an extremely 
efficient detoxification of the reactive epoxide (Monroe and Eaton, 1987; Quinn et 
al., 1990; Hayes et al., 1991). In CCI4 and AFBi intoxification of rats，allyl sulfides 
(principal constituents of garlic oil) and garlic powder in diet (5%) had significantly 
induced the activities of GST in rats and at the same time they reduced the level of 
liver injury (indicated by the activities of SGPT/SGOT) and the number of 
preneoplastic foci (sign of carcinogenesis) induced by the toxins (Berges et al” 2004; 
Fukao et al., 2004). 
Reactive oxygen species (ROS) are produced during the metabolisms of both 
CCI4 and AFB, (Shen et al., 1996; Liu et al,, 1999; Stoyanovsky and Cederbaum, 
1999). Oxidative stress, which is produced by ROS, has been increasingly 
recognized as a pivotal mechanism contributing to the toxicity of many xenobiotics 
(Boelsterli, 2003). Oxygen intermediates (e.g. superoxide anion radical，hydrogen 
peroxide, and hydroxyl radical) are produced during the partial and stepwise 
reduction of molecular oxygen in the redox reaction in cell. Oxidative stress can 
have multiple toxic consequences. Targets for oxidative damage are nucleic acids, 
proteins, and lipids (Boelsterli, 2003). It has been increasingly recognized that the 
extent of oxidative stress needs to be excessive in order to damage most organs, as 
the antioxidant defense in cells is strong and can be regulated or induced by 
transcriptional activation (Boelsterli, 2003). Oxidative nuclear and mitochondrial 
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DNA damages can be the basis for tumor formation, while oxidative protein damage 
leads to loss of enzymatic functions or impairment of function for structural protein. 
Oxidative lipid damage may result in lipid peroxidation in which damage of a 
membrane lipid is readily amplified and propagated across the biomembrane by the 
effect of reactive products produced (Boelsterli, 2003). Lipid peroxidation is the 
prime mechanism of tissue injury induced by CCI4 (Recknagel, et al., 1989; 
Boelsterli, 2003). AFB, intoxication also leads to lipid peroxidation evidenced by 
the dose-dependent formation of malonaldehyde (MDA) (Shen et al., 1994). Lipid 
peroxidation and oxidative DNA damage are the principal manifestations of 
aflatoxin B1-induced toxicity which could be mitigated by antioxidants (Souza et al, 
1999). Apart from membrane injury, toxic aldehydes including MDA produced are 
able to covalently bind to proteins or DNA (Boelsterli, 2003). A number of dietary 
constituents have been identified to possess hepatoprotective effect in reducing ROS 
production in CCI4- and AFB,-intoxication. Rooibos tea and S. miltiorrhiza (a 
traditional Chinese medicine) have been proved to reduce lactate dehydrogenase 
leakage and MDA concentration in liver, which have been used as lipid peroxidation 
biomarker (Liu et al., 1999; Ulicna et al., 2003). Moreover，vitamin E (an 
antioxidant) and tematin (a tetramethoxyflavone isolated from Egletes viscose), had 
been shown to possess hepatoprotective effect against CCI4- and AFB,-induced liver 
injury in vivo (Parola et al, 1992; Souza et al, 1997; Souza et al., 1999). 
In the present research, these 2 chemicals produced different adverse effects to 
the liver. This was evident by the present results of the liver per body weight, and 
indirectly, the hepatoprotective effect by 30% Ptr sclerotial diet to the CCI4 and 
AFB 丨 control groups. Liver per body weight ratios of CCU-intoxified rats were 
increased as compared to the control, while that of AFBi-intoxified rats were 
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decreased. Although there is no literature stating directly the cause of liver weight 
change, it is speculated that, the decrease of relative liver weight would probably 
due to the inhibition of DNA，RNA, protein synthesis and the absent of hepatic 
parenchymal cell proliferation (Busby and Wogan, 1984). In rat, the increase in liver 
weight (liver hypertrophy) is considered to be benign and adaptive changes in 
response to certain chemicals that stimulate the hepatic drug metabolizing enzyme 
system and is not inextricably linked to the magnitude of metabolizing enzyme 
induction (Amacher et al., 1998). The increased in liver weight induced by CCI4 
might due to the accumulation of fat from lipid peroxidation, in which some of them 
were of high molecular mass due to cross linking (Link et al, 1984). Besides, 1.5 
ml/kg CCI4 were also used for Ptr sclerotium preventive hepatoprotection test (data 
not shown) in which the SGPT activity (1052 土 332.0 lU/L) were comparable to that 
of rats intoxicated by 0.7 mg/kg AFBi (1681 士 650.3 lU/L) (Figure 3.18c). The 
consumption of 30% Ptr sclerotial diet showed different extent of preventive 
protection effect to the rats intoxicated with CCI4 and AFBi. Ptr sclerotium reduced 
AFBi-elevated SGPT activity by 64% but was not effective against CCI4. These 
results implied that CCI4 and AFBi may exert their adverse effects to rats with 
different mechanisms and that Ptr sclerotium may possess different hepatoprotective 
mechanisms towards these two toxins. Further investigations need to be carried out 
for identification of the underlying mechanisms. 
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3.4 Summary 
Ptr sclerotium showed hepatoprotective flinction against CCI4 and AFB, 
intoxication in vivo in this research. At the concentration of 30% in the diet, Ptr 
sclerotium enhanced the recovery rate of liver after the intoxication of 1.5 ml/kg 
CCI4 as revealed by histopathological study. It also preventively lowered the liver 
injury induced by 0.7 ml/kg CCI4 indicated by SGOT activities. In rats intoxicated 
with 0.7 mg/kg AFB,, 30% Ptr sclerotial diet showed conspicuous preventive 
hepato- and geno-protective effects. Ptr sclerotium protected against AFBi induced 
liver weight reduction, attenuated the elevation of serum transaminase activities and 
increase of comet tail intensity. The exact mechanism of Ptr sclerotium 
hepatoprotective against these 2 toxins requires further investigations. 
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Chapter 4 Conclusions and future work 
According to the biochemical and histopathological results of the toxicity tests 
on Ptr sclerotium, a single dose of intake up to 80.27g/kg body wt. and a 90-day 
daily intake of 6.44 g/kg body wt. did not have acute and sub-chronic effect 
respectively on the rats. A 90-day feeding of 20% Ptr sclerotial diet led to hepatic 
necrosis in male rats，suggesting sub-chronic intake of Ptr sclerotium at this dose 
might impose adverse effect to the liver with males being more vulnerable than 
female at the same age. 
The present study suggested that Ptr sclerotium is able to prevent 
hepatotoxicity against CCI4 and AFBi intoxication in vivo. The present study 
represents only the first stage of the investigation on the hepatoprotective effect of 
Ptr sclerotium against CCI4- and AFBi-induced injury. The exact mechanism of the 
hepatoprotective effect requires further investigations but might include cell division 
enhancement to promote regeneration or recovery from the damage in the liver, free 
radical scavenging, complexation of the toxins and modulations on the expression of 
bioactivation or detoxification enzymes in the animals. 
Ptr sclerotium has been proven to have anti-tumor and anti-virus activity, as 
well as to increasing immunological functions in rats. With the findings of the 
present study, Ptr sclerotium can be used to protect against several diseases when 
administered at a suitable amount. The suggested amount of Ptr sclerotium 
consumption is 80.27g/kg body wt. for acute intake, and 6.44 g/kg body wt. for 
90-day sub-chronic intake. 
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The lowest percentage of Ptr sclerotial diet (5%) tested in the subchronic 
toxicity test still showed some adverse effect to the liver of male rats. Therefore, 
range of lower doses of sclerotial diet can be used to find the NOAEL. For example, 
O.50/�’ 10/0 and 2% of Ptr sclerotial diet can be tested in future subchronic toxicity 
test. 
In addition to light microscopy, transmission electron microscopy (TEM) can 
be used which can reveal possible damage to the organelles inside the cells. This 
aids in the investigation of possible mechanism of subchronic consumption of high 
Ptr sclerotial diet. 
Proximate analysis can be used to evaluate the portion of Ptr sclerotium left in 
stool that is undigested (AOAC, 1996). As raw Ptr s c l e ro t i c was used in the diets, 
the adverse effects to the rats or the protective effects against toxicants were present 
only after the digestion the Ptr sclerotium. The amount of Ptr sclerotium that can be 
digested in a diet by rat within a period of time (e.g. one day) should be quantified 
so as to evaluate the amount of effective Ptr sclerotium in the diet. 
It has been suggested that organ weight values with respect to brain weight 
rather than to body weight may be more preferable, if body weight changes are 
substantial (Hodge and Gosselin, 1997). Therefore, the relative change in liver 
weight can be more accurately reflected by the ratio. 
A 90-day subchronic toxicity test usually cannot determine the carcinogenic 
potential of a test substance (FDA, 2000). It is suggested that Ames test can be used 
to evaluate the mutagenicity of Ptr sclerotium. As Ptr sclerotium is not soluble in 
149 
water, aqueous extractions of Ptr sclerotium can be prepared for this test. 
Liver of rats fed with Ptr sclerotial diet before the intoxication of AFB, could 
be processed to obtain microsomal and cytosolic fractions for the enzyme assays 
(enzyme activities) and Western blots (enzyme quantities) of phase I CYPs (e.g. 
CYP3A, 2B, 2C and lA), and phase II GST or UDP-glucuronosyl transferase (e.g. 
GSTA5) quantities. The CYPs mentioned have been considered to activate AFB, 
into toxic and carcinogenic AFBi-8,9-epoxide, while GST have been identified as 
playing major roles in the detoxification of this active metabolite (Manson et al., 
1997; Miyata et al, 2004). For CCI4, Western blot can be used in quantifying the 
CYP2E1, the major isozyme involved in CCI4 bioactivation, and GST isozymes. The 
possible effect of Ptr sclerotium on the modulation of phase I and II enzymes against 
AFBi and CCI4 can thus be investigated. 
With the evidences found in this research and others, Ptr sclerotium and its 
isolated bioactive components pose a significant impact on the food and 
pharmaceutical industry by their potential uses in disease prevention and curation. 
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